HoldsUp

The Diary Of A CEO · 2026-03-30 · Steven Bartlett (host), Rhonda Patrick

Anti-Aging Expert: Stop Touching Receipts Immediately! The Fast Way To Shrink Visceral Fat!

131 research-tied claims examined: 8 contradicted 28 overstated 12 context 73 supported 10 unverified

8 Contradicted by research
0:14:50Rhonda Patrickcontradictedmoderate

In a study of healthy young men restricted to 4 hours of sleep per night for 2 weeks, participants gained 11% visceral fat without gaining weight on the scale.

"These men were only sleeping four hours a night for two weeks. Okay, these are healthy young men, college-age students, young. They gained 11% visceral fat after that two weeks, but not a pound on the scale, but they had 11% higher visceral fat after just, you know, two weeks of not getting enough sleep." (said at 0:14:50)

The speaker is referring to a randomized crossover trial led by Covassin et al. (PMID 35361348) at the Mayo Clinic, in which 12 healthy non-obese participants (9 men, 3 women, aged 19–39) underwent 14 days of sleep restriction (4-hour sleep opportunity per night). The study did observe an approximate 11% increase in visceral abdominal fat (P = 0.042) alongside increased caloric intake. However, the speaker's claim that participants gained 'not a pound on the scale' is contradicted by the study findings: participants gained a statistically significant amount of weight during the sleep restriction condition compared to control sleep (~0.5 kg / 1.1 lbs, P = 0.008).

0:24:41Rhonda Patrickcontradictedhigh

Resistance training and lifting weights do not significantly reduce visceral fat, whereas vigorous aerobic exercise such as running, cycling, or swimming does.

"So what I mean is resistance training and lifting weights don't really move the needle in terms of helping you lose visceral fat... But if you want to lose visceral fat, you're going to have to do running, jogging, cycling, swimming." (said at 0:24:41)

Multiple systematic reviews and meta-analyses of randomized controlled trials demonstrate that resistance training alone produces statistically significant reductions in visceral adipose tissue (VAT), directly contradicting the claim that lifting weights 'doesn't move the needle' for visceral fat loss. While vigorous aerobic exercise and high-intensity interval training (HIIT) generally demonstrate greater relative efficacy than resistance training in head-to-head network comparisons, aerobic exercise is not strictly required to achieve significant visceral fat reduction.

0:36:27Rhonda Patrickcontradictedmoderate

Obesity accelerates ovarian aging and leads to earlier menopause.

"Obesity accelerates ovarian aging. So you're more likely to go into menopause earlier with obesity." (said at 0:36:27)

Large prospective cohort studies and meta-analyses consistently demonstrate that higher body mass index (overweight and obesity) is associated with a later age at natural menopause (or a lower risk of early natural menopause), rather than an earlier menopause. In contrast, being underweight is associated with an increased risk of early menopause. This is thought to be mediated in part by the peripheral conversion of androgens to estrogens in adipose tissue.

0:46:38Rhonda Patrickcontradictedhigh

Approximately 20% of male infants are born with an undescended testicle.

"Something like 20% of boys now have an undescended testicle. I mean, it's crazy." (said at 0:46:38)

Epidemiological data and systematic reviews demonstrate that the true prevalence of undescended testes (cryptorchidism) at birth is approximately 1.0% to 4.6% (and up to 9% in some prospective cohorts) in term newborn boys, far below the claimed 20%. While premature or low birth weight infants (<2.5 kg) can have significantly higher rates of cryptorchidism due to incomplete testicular descent before 35 weeks of gestation, spontaneous descent typically occurs in the first months of life, reducing the overall prevalence to approximately 1.0% to 1.5% by age one.

1:09:43Rhonda Patrickcontradictedmoderate

Non-liposomal oral glutathione is not effectively absorbed or transported into human cells because cells lack transporters for external glutathione.

"The problem is because our body makes it inside of our cells, we don't have a transporter to get glutathione from the outside of our cells, like if we eat it and if it makes it through our digestion, which it really doesn't, into our cells. And so this kind of glutathione isn't going to make it inside of your cells." (said at 1:09:43)

The speaker claimed that non-liposomal oral glutathione cannot make it through digestion or enter human cells because cells completely lack transporters to import extracellular glutathione. This is contradicted by both clinical trial data and in vitro cellular uptake studies. In a randomized, double-blind, placebo-controlled trial in healthy adults (PMID 24791752), daily oral supplementation with plain glutathione significantly increased intracellular glutathione stores across multiple cell types (including erythrocytes, lymphocytes, and buccal cells) by 30% to 260% in a dose- and time-dependent manner. Additionally, comparative cellular uptake assays show that while liposomal formulations enhance uptake, plain non-liposomal glutathione is still taken up intracellularly (e.g., ~23% uptake in HEK 293T cells; PMID 41559937). Although intact oral glutathione has lower bioavailability and undergoes degradation into its constituent amino acids (which are then transported and resynthesized into intracellular GSH) alongside direct transport mechanisms, the blanket assertion that it 'isn't going to make it inside of your cells' due to a total absence of cellular uptake/transport is contradicted.

1:35:55Rhonda Patrickcontradictedlow

Old mice administered urolithin A showed tissue rejuvenation and a 20% lifespan extension.

"old mice that were given urolithin A were able to rejuvenate tissues, but also a 20% life extension was found in these mice given urolithin A. 20% is pretty big for a mouse study." (said at 1:35:55)

The speaker confuses findings in C. elegans (roundworms) with findings in mice. In the seminal 2016 Nature Medicine study by Ryu et al. (PMID: 27400265), urolithin A treatment extended lifespan by ~45% in C. elegans, while in mice and rats, it improved exercise capacity, muscle function, and tissue markers (healthspan/rejuvenation parameters), but lifespan extension was not demonstrated or reported in the mice.

1:44:50Rhonda Patrickcontradictedmoderate

Beta-hydroxybutyrate increases brain GABA levels, elevates BDNF, and reduces cellular oxidation.

"I have that beta-hydroxybutyrate which is increasing GABA, that inhibitory neurotransmitter that's silencing down some of the anxiety in the back of the brain or the chatter and just helping me focus. And also it increases brain-derived neurotrophic factor. So beta-hydroxybutyrate is a signaling molecule. It's able to increase brain-derived neurotrophic factor in the brain that helps with learning, memory, brain aging. It's also been shown to lower oxidation." (said at 1:44:50)

The speaker bundles three claims regarding beta-hydroxybutyrate (BHB): that it increases brain GABA, elevates brain-derived neurotrophic factor (BDNF), and reduces oxidation. In vivo human neuroimaging directly contradicts the GABA assertion: 7T proton magnetic resonance spectroscopy demonstrated that acute administration of D-BHB significantly decreased (downregulated) rather than increased cortical GABA and glutamate levels in healthy adults. Furthermore, randomized controlled trials of exogenous BHB supplementation in humans and rodents failed to detect increases in BDNF levels, although ketogenic diets elevate circulating BDNF in some contexts. Antioxidant effects of BHB have primarily been observed in preclinical and cellular models. Because the primary neurochemical mechanism (increasing GABA) is inverted relative to human experimental data, the claim is contradicted.

2:04:17Rhonda Patrickcontradictedmoderate

Studies show that London taxi drivers do not get Alzheimer's disease.

"there's studies out there showing that these these types of um taxi drivers like do not get Alzheimer's disease." (said at 2:04:17)

Studies do not show that London taxi drivers are immune to Alzheimer's disease. While landmark neuroimaging research on London taxi drivers demonstrated hippocampal neuroplasticity and increased posterior hippocampal gray matter volume associated with spatial navigation training ("The Knowledge"), these studies did not evaluate disease immunity. Furthermore, epidemiological and clinical data show that taxi drivers can and do develop and die from Alzheimer's disease (e.g., a population-based study of US mortality data found 171 Alzheimer's deaths among 16,658 taxi drivers, and published case studies document Alzheimer's disease in former taxi drivers).

28 Overstated
0:00:29Rhonda Patrickoverstatedlow

Receipts are coated with BPA, and a study in adolescent boys showed BPA exposure was associated with a 50% reduction in testosterone.

"That's bad. That's covered with BPA, and a study in adolescent boys showed that it was associated with a 50% reduction in testosterone." (said at 0:00:29)

While thermal receipts frequently contain bisphenol A (BPA) as a developer, epidemiological evidence in adolescent boys does not demonstrate a 50% reduction in testosterone from typical BPA exposure. Observational cohort and cross-sectional studies (such as NHANES analyses) evaluating endocrine disruptors and sex hormones in children and adolescents report modest, inconsistent, or non-statistically significant associations between urinary BPA and testosterone in males, with larger negative associations typically driven by other compounds (like phthalates) or observed in animal models at supraphysiological doses.

0:12:08Rhonda Patrickoverstatedlow

On a DEXA scan, a healthy target is to have less than 300 grams of visceral fat.

"You really want to have below 300 grams of visceral fat; ideally closer to zero the better." (said at 0:12:08)

While lower levels of visceral adipose tissue (VAT) are associated with reduced cardiometabolic risk, establishing a universal clinical target of <300 grams on DXA—and asserting that 'closer to zero the better'—is overstated. In clinical DXA studies and normative reference cohorts, healthy adult VAT values frequently exceed 300 g, and validated thresholds for predicting metabolic syndrome and cardiometabolic dysfunction are substantially higher (typically ranging from ~500 g to over 1300 g depending on sex, age, and DXA system). Adipose tissue also serves essential endocrine and protective physiological roles, making an arbitrary target of zero inappropriate.

0:31:52Rhonda Patrickoverstatedmoderate

Exercising in a fasted state increases mitochondrial adaptations compared to exercising fed.

"So you have what are called mitochondrial adaptations that are better. You make more mitochondria... Both, even if you're not, but if you're fasted, it's even better." (said at 0:31:52)

While exercising in a fasted state acutely augments certain upstream metabolic signaling pathways (such as AMPK phosphorylation and PDK4 expression), human randomized trials investigating chronic training adaptations show that markers of mitochondrial biogenesis and mitochondrial enzyme capacity (such as citrate synthase activity and PGC-1alpha expression) increase similarly whether exercise is performed in a fasted or fed state. Stating definitively that fasted training results in 'better' mitochondrial adaptations or 'making more mitochondria' overstates the evidence.

0:45:15Rhonda Patrickoverstatedlow

A study found that adolescent boys with the highest BPA levels had 50% lower testosterone compared to boys with the lowest BPA levels.

"Adolescent boys that had the highest amount of BPA had 50% lower testosterone than the boys that had the lowest amount of BPA." (said at 0:45:15)

Epidemiological studies examining urinary bisphenol A (BPA) and reproductive hormones in adolescent boys (e.g., in NHANES and cohort studies) show mixed or modest associations, but none document a 50% reduction in serum testosterone between the highest and lowest BPA exposure groups. In large cross-sectional studies (such as NHANES cohorts), BPA associations with testosterone in adolescent males are typically modest, inconsistent across subgroups, or non-significant, making a 50% drop a substantial overstatement of human observational evidence.

0:47:21Rhonda Patrickoverstatedlow

Pregnant women with high BPA levels are six times more likely to have a child diagnosed with autism spectrum disorder compared to women with low BPA levels.

"there's even studies now with women, pregnant women that have high levels of BPA, they're six times more likely to have a child with autism spectrum disorder compared to women with low levels of BPA." (said at 0:47:21)

A 2024 prospective birth cohort study (the Barwon Infant Study, n = 1,074, published in Nature Communications) evaluated prenatal maternal BPA exposure and autism spectrum disorder (ASD). In that study and its accompanying media coverage, higher prenatal BPA exposure was associated with an approximately six-fold increased odds of an ASD diagnosis by age 9, but this association was specific to male offspring and was restricted to boys with low aromatase genetic pathway activity scores (rather than applying universally to all pregnant women and children). The speaker overstates the finding by presenting the six-fold risk as an unconditional effect across all children, omitting the essential sex-specific and genetic moderation constraints.

0:48:37Rhonda Patrickoverstatedlow

Sulforaphane activates phase 2 detoxification enzymes that make BPA water-soluble for excretion in urine.

"Sulforaphane activates a pathway that are enzymes involved in making BPA become water soluble so they come out your urine." (said at 0:48:37)

Sulforaphane is a potent activator of the Nrf2 pathway, which upregulates phase II detoxification enzymes (such as glutathione S-transferases and UDP-glucuronosyltransferases) that conjugate xenobiotics to make them water-soluble for urinary excretion. Randomized clinical trials have demonstrated that sulforaphane enhances the urinary excretion of volatile airborne pollutants such as benzene and acrolein (PMID: 24913818). While bisphenol A (BPA) is naturally metabolized and made water-soluble via phase II glucuronidation, no clinical or in vivo pharmacokinetic studies specifically demonstrate that sulforaphane increases the urinary clearance or excretion of BPA. Extrapolating evidence from airborne pollutant detoxication directly to BPA excretion overstates the available evidence.

0:50:04Rhonda Patrickoverstatedlow

There are 12 published clinical studies showing that the sulforaphane supplement Avmacol improves symptoms in children and adolescents with autism spectrum disorder.

"The supplement I take is called Avmacol. It's by a company called Nutramax... they've got 12 published studies using it, clinical studies, too, showing that it actually helps with autism. Children and adolescents with autism that take the sulforaphane supplement, that they have improved symptoms because it's a detox." (said at 0:50:04)

The speaker significantly overstates the volume and consistency of clinical trial evidence. A 2025 meta-analysis identified a total of only 6 randomized controlled trials (333 total participants) evaluating sulforaphane in autism spectrum disorder across all formulations, not 12 published clinical trials for Avmacol. Furthermore, the findings among existing trials are mixed: while some small trials reported improvements on specific behavioral scales or as an adjunctive treatment, other trials found no statistically significant difference compared to placebo on primary behavioral outcome measures.

0:50:32Rhonda Patrickoverstatedvery low

Individuals with autism spectrum disorder are 30 times less likely to excrete BPA compared to neurotypical individuals.

"interestingly, people with autism are like 30 times less likely to excrete BPA." (said at 0:50:32)

Preliminary observational studies by Stein and colleagues indicate that children with autism spectrum disorder (ASD) have a modest reduction in the efficiency of BPA glucuronidation (the main metabolic pathway enabling BPA excretion in urine), but the magnitude of the difference is vastly overstated. In a 2023 case-control study of children with ASD (n=66) and neurotypical controls (n=37), BPA glucuronidation efficiency was reduced by approximately 11% (p = 0.020), not 30-fold (3,000%). The speaker likely conflated statistical figures or correlation thresholds from earlier metabolomic analyses with excretion capacity.

0:49:00Rhonda Patrickoverstatedmoderate

During fetal development, estrogen plays an essential role in masculinizing regions of the male brain.

"Believe it or not, when you're a boy developing in your mom's womb, estrogen plays a very important role in your brain and brain development and what's called masculinizing the male brain." (said at 0:49:00)

The speaker is describing the classic 'aromatization hypothesis,' in which fetal testosterone is converted locally in the brain to estradiol (estrogen) to induce masculinization and defeminization of neural circuits. While this mechanism is well-established in rodents, extensive human genetic and clinical evidence shows that brain masculinization in human males is primarily mediated directly by androgen receptors, not estrogen receptors. Genetic human males with aromatase deficiency or estrogen receptor mutations still develop male gender identity and male-typical behaviors, whereas individuals with complete androgen insensitivity syndrome develop female phenotypes and identities.

1:05:43Rhonda Patrickoverstatedlow

In adolescent boys, high urinary BPA levels are associated with a 50% reduction in testosterone levels.

"we talked about that study in adolescent boys where they had high BPA levels and that was associated with a 50% reduction in testosterone." (said at 1:05:43)

Epidemiological studies using NHANES data (such as Scinicariello & Buser, 2016) have reported that higher urinary BPA concentrations are cross-sectionally associated with significantly lower serum total testosterone in adolescent males (12-19 years). However, the claim of a '50% reduction in testosterone levels' overstates the magnitude of this observational association, which is based on cross-sectional survey data with modest relative differences across quartiles, not a halving of hormone levels. Moreover, cross-sectional observational data cannot establish causality.

1:15:36Rhonda Patrickoverstatedmoderate

Some over-the-counter vitamin D3 and melatonin supplements have been found to contain 1,000 to 10,000 times more active ingredient than stated on the label.

"some vitamin D3 supplements and some melatonin supplements have like some, in some cases, like 1,000- to 10,000-fold more. And it was a really big problem with melatonin, because melatonin is that hormone that you make to help you fall asleep and there was excessive amounts in them." (said at 1:15:36)

While manufacturing errors and poor quality control in dietary supplements have led to severe mislabeling, the claim that supplements contain 1,000 to 10,000 times the labeled amount is vastly overstated, particularly for melatonin. For vitamin D3, rare industrial manufacturing and compounding errors have led to massive overdoses (ranging from tens to hundreds or occasionally a thousand times the intended dose, leading to severe hypervitaminosis D and hypercalcemia). However, systematic analyses of commercial over-the-counter melatonin products show discrepancies typically ranging from -83% to +478% of the labeled dose (under a 5-fold excess), far below the claimed 1,000- to 10,000-fold excess.

1:18:20Rhonda Patrickoverstatedlow

A high omega-3 index is associated with a 66% lower risk of developing Alzheimer's disease.

"you have a 66% lower chance of getting Alzheimer's disease with a high omega-3 index." (said at 1:18:20)

Prospective observational data from the Framingham Offspring Cohort found that individuals in the highest quintile of red blood cell (RBC) docosahexaenoic acid (DHA) had a 49% lower risk of incident Alzheimer's disease compared to those in the lowest quintile (HR: 0.51, 95% CI: 0.27-0.96). Claiming a '66% lower chance' overstates the observed risk reduction (49%), and observational associations cannot establish direct causation.

1:18:28Rhonda Patrickoverstatedmoderate

In a Swiss trial of active older adults (DO-HEALTH), combining omega-3, vitamin D, and resistance training slowed epigenetic biological aging by four months over one year.

"a study showed that omega-3 fish oil supplementation, this was a study out of Switzerland... The combination of all three slowed it by four months. This was just after one year." (said at 1:18:28)

In a post hoc analysis of the DO-HEALTH randomized controlled trial (PMID 39900648, published in Nature Aging in 2025), combining omega-3 (1 g/day), vitamin D3 (2,000 IU/day), and a simple home exercise program showed an additive slowing effect on the PhenoAge DNA methylation clock. However, the slowing effect of 2.9 to 3.8 months (~0.32 units) was observed across the full 3-year trial period, not 'just after one year', making the speaker's implied rate of biological age deceleration roughly three times faster than what the trial demonstrated.

  • partial: Individual and additive effects of vitamin D, omega-3 and exercise on DNA methylation cloc… (Nature aging 2025) · cited 126x in the literature
    "Here, we report the results of a post hoc analysis among 777 participants of the DO-HEALTH trial on the effect of vitamin D (2,000 IU per day) and/or omega-3 (1 g per day) and/or a home exercise program on four next-generation DNA methylation (DNAm) measures of biological aging (PhenoAge, GrimAge, GrimAge2 and DunedinPACE) over 3 years. Omega-3 alone slowed the DNAm clocks PhenoAge, GrimAge2 and DunedinPACE, and all three treatments had additive benefits on PhenoAge. Overall, from baseline to year 3, standardized effects ranged from 0.16 to 0.32 units (2.9-3.8 months)." (abstract, results)
    pubmedfull study (doi)
1:19:14Rhonda Patrickoverstatedmoderate

In the DO-HEALTH trial, participants receiving the combined intervention of omega-3, vitamin D, and exercise had a 60% lower risk of pre-frailty.

"within that study, they looked at real-world outcomes. So that also correlated with they had a 60% less likely chance of being pre-frail. So pre-frailty, right? They also were less likely to get cancer as well." (said at 1:19:14)

In a secondary analysis of the DO-HEALTH trial (PMID 36629088), the triple combination of supplemental vitamin D3 (2,000 IU/day), marine omega-3 fatty acids (1 g/day), and a home exercise program was associated with an odds ratio of 0.61 (95% CI 0.38-0.98) for incident pre-frailty compared to control. This represents a 39% reduction in the odds of becoming pre-frail, not a 60% lower risk. The speaker likely conflated the odds ratio value of 0.61 with a 60% reduction, or mixed it up with the trial's cancer analysis (PMID 35821820), which reported an adjusted hazard ratio of 0.39 (~61% risk reduction) for invasive cancer.

1:21:11Rhonda Patrickoverstatedlow

Studies from Germany demonstrate that a 10-gram daily dose of creatine increases creatine accumulation in human brain regions, whereas lower doses do not.

"Studies out of Germany show that once you get to the 10-gram mark, your brain is able to take it up and it's increasing creatine in certain brain regions. That doesn't happen much at lower doses, and that's because your muscles are very greedy." (said at 1:21:11)

The speaker appears to reference landmark proton magnetic resonance spectroscopy (1H-MRS) research from Germany (e.g., Dechent et al., 1999, conducted at the Max Planck Institute in Göttingen), which demonstrated that oral creatine supplementation increases total creatine in specific human brain regions (such as gray matter, white matter, cerebellum, and thalamus). However, the claim is overstated regarding the specific dosage: the seminal German study utilized a high dose of 20 g/day (4 x 5 g/day for 4 weeks), not 10 g/day. While researchers commonly hypothesize that higher dosages (often 10–20 g/day) are required to significantly increase brain creatine compared to muscle saturation doses due to the blood-brain barrier and creatine transporter dynamics, literature reviews (e.g., PMID 41556609) note that brain uptake responses remain variable and dose/duration dependency across defined thresholds like 10 g/day is not definitively established.

1:21:40Rhonda Patrickoverstatedmoderate

High-dose creatine supplementation (20 to 25 grams) negates the negative cognitive performance effects caused by acute sleep deprivation.

"studies have shown if you go up to a higher dose like that, depending on your weight—it's kind of a scale—that it helps you basically negate the negative effects on your brain from sleep deprivation, where not only are you cognitively functioning, you're functioning beyond what your normal baseline was" (said at 1:21:40)

Studies have examined high-dose creatine supplementation (such as a single dose of 0.35 g/kg, roughly 20–25 g for typical body weights, or 20 g/day loading for 7 days) during acute sleep deprivation. Randomized trials (e.g., Gordji-Nejad et al., 2024; McMorris et al., 2006) demonstrate that high-dose creatine can partially attenuate or reduce the cognitive declines associated with acute sleep deprivation, especially in processing speed, executive function, and working memory tasks. However, the claim that it completely 'negates' the cognitive consequences of sleep deprivation or enables cognitive functioning 'beyond what your normal baseline was' is an overstatement. A recent systematic review (2026) highlights that while preliminary results are positive, the evidence base is small and benefits are domain-specific and partial rather than restorative beyond baseline.

1:33:41Rhonda Patrickoverstatedlow

Curcumin supplementation improves exercise performance by reducing inflammation.

"And also it's been shown to improve performance in people that are exercising, again because it's reducing inflammation. Inflammation can be dampening for performance." (said at 1:33:41)

While curcumin supplementation has anti-inflammatory and antioxidant properties that can reduce markers of exercise-induced muscle damage (such as creatine kinase and pro-inflammatory cytokines like IL-6 and TNF-α) and decrease subjective muscle soreness, evidence that it directly improves physical or athletic performance is inconsistent and weak. Systematic reviews and meta-analyses note that only a subset of small, heterogeneous trials report performance improvements, with meta-analyses often finding no significant difference in functional muscular performance recovery compared to placebo.

1:37:14Rhonda Patrickoverstatedmoderate

Supplementing with 1,000 mg per day of urolithin A improves VO2 max by 10% more than exercise alone in untrained athletes, and by 5% in trained athletes.

"Younger adults that have taken it—so there's been studies showing that untrained athletes supplementing with 1,000 milligrams a day were able to improve their VO2 max 10% more than just exercise alone. So if they exercised and took urolithin A, their VO2 max went up 10% compared to the exercise-alone group... If they were trained athletes, it only went up 5% because trained athletes already are doing a lot, right?" (said at 1:37:14)

The speaker overstates and conflates the published clinical trial results on Urolithin A (UA). In highly trained male distance runners (PMID 40839339), 1,000 mg/day of UA for 4 weeks produced a within-group VO2 max increase of 5.4% (from 66.4 to 70.0 mL/kg/min), but the placebo group also improved by 3.6%, and the between-group difference (time x treatment interaction) was not statistically significant (p = 0.138), with no overall enhancement in 3,000 m running performance. In middle-aged adults (PMID 35584623), 1,000 mg/day of UA improved peak VO2 by ~10% over placebo in sedentary/untrained individuals without an exercise training intervention (it was not a trial testing UA plus exercise vs. exercise alone in young untrained athletes). Claiming a definitive additive 10% improvement over exercise alone in untrained athletes and a 5% improvement in trained athletes misrepresents the study designs, populations, and statistical significance.

1:38:00Rhonda Patrickoverstatedmoderate

Urolithin A supplementation in older adults improved hamstring muscle strength by 10% to 12% compared to exercise alone.

"So it's been shown to increase muscle strength in older adults. So their hamstring strength improved by like 10 to 12% after supplementing versus just exercise alone." (said at 1:38:00)

The speaker misattributes the population and study comparator. A 4-month randomized, placebo-controlled trial by Singh et al. (2022) in middle-aged adults (ages 40–65) found an approximately 12% improvement in hamstring muscle strength (knee flexion peak torque) with 1,000 mg/day Urolithin A supplementation compared to placebo. However, this was tested in middle-aged adults (not older adults) and compared against a placebo control, not an 'exercise alone' intervention. In a separate trial in older adults aged 65–90 (Liu et al., 2022), Urolithin A improved muscle endurance in specific hand and leg muscles over placebo, but did not measure hamstring strength or test against exercise alone.

1:38:20Rhonda Patrickoverstatedmoderate

Meta-analyses show that consuming pomegranate juice before exercise over several weeks can increase VO2 max by up to 17%.

"And there are studies showing that people that take pomegranate juice before they exercise, over the course of several weeks, can actually increase their VO2 max by up to 17%. This is analysis of multiple studies showing that." (said at 1:38:20)

No meta-analyses or systematic reviews show that consuming pomegranate juice before exercise over several weeks increases VO2 max by up to 17%. Systematic reviews and meta-analyses evaluating polyphenol- and nitrate-rich food sources (such as pomegranate) have found only small or trivial improvements in endurance exercise performance metrics (e.g., standardized mean difference [SMD] = 0.17), not a 17% increase in VO2 max. The speaker appears to have conflated a standardized effect size of 0.17 with a 17% improvement in aerobic capacity. While pomegranate supplementation has demonstrated modest benefits for exercise recovery, blood flow, and time-to-exhaustion in small trials, there is no evidence demonstrating a massive up-to-17% gain in VO2 max.

1:39:20Rhonda Patrickoverstatedlow

Glutamine supplementation reduces the incidence of respiratory illness in endurance athletes.

"Studies were showing that if those endurance athletes supplemented with glutamine, they didn't get sick as often. They were having fewer respiratory illnesses." (said at 1:39:20)

Early clinical trials in the late 1990s (e.g., Castell et al., 1997) reported that endurance athletes (marathon and ultra-marathon runners) who consumed glutamine after prolonged exhaustive exercise had a lower incidence of self-reported infection over the following 7 days. However, subsequent systematic reviews and meta-analyses (such as Bermon et al., 2007) concluded that broader evidence failed to confirm a consistent or significant reduction in upper respiratory tract infections with glutamine supplementation.

2:00:41Rhonda Patrickoverstatedmoderate

Learning a new language is associated with a decrease in the risk of Alzheimer's disease.

"That's why learning a new language is associated with a rapid, you know, decrease in Alzheimer's disease risk. You're working your brain. You're learning new things." (said at 2:00:41)

The speaker claims that learning a new language is associated with a 'rapid decrease in Alzheimer's disease risk.' While observational studies and meta-analyses suggest that bilingualism contributes to cognitive reserve and is associated with a delay in the onset of Alzheimer's disease symptoms and diagnosis (by approximately 4 to 5 years), meta-analyses demonstrate that bilingualism is not associated with a statistically significant reduction in the overall risk (incidence) of developing dementia. Furthermore, there is no clinical evidence demonstrating a 'rapid' reduction in Alzheimer's risk from learning a language.

2:11:54Rhonda Patrickoverstatedmoderate

An accelerometer study found that for all-cause mortality reduction, 1 minute of vigorous-intensity exercise is equivalent to 4 minutes of moderate-intensity exercise and 100 to 150 minutes of light physical activity.

"for every one minute of vigorous-intensity exercise, you had to do 4 minutes of moderate intensity and you had to do like 100 to 150 minutes of light exercise to get the same reduction in all-cause mortality." (said at 2:11:54)

A 2025 prospective cohort study of 73,485 UK Biobank participants with wearable accelerometers (Nature Communications, PMID 41057301) evaluated health equivalence across physical activity intensities. For all-cause mortality risk reduction (5%-35%), 1 minute of vigorous physical activity (VPA) was equivalent to a median of 4.1 minutes (95% CI: 4.1-4.2) of moderate physical activity (MPA), matching the speaker's claim of 4 minutes. However, the median light physical activity (LPA) equivalent for all-cause mortality was 53 minutes per minute of VPA (ranging up to 94 minutes for type 2 diabetes), making the speaker's estimate of '100 to 150 minutes' for all-cause mortality an overstatement.

2:13:58Rhonda Patrickoverstatedlow

Women who performed 3.5 minutes of daily vigorous intermittent physical activity lowered their cancer risk by 40%.

"Women that did three and a half minutes of just this vigorous types of exercise per day lowered their cancer risk by 40%. Yes, three and a half minutes a day. This was in women." (said at 2:13:58)

The claim mischaracterizes the findings from a 2023 prospective cohort study of UK Biobank accelerometry data (PMID 37498576). First, the study was conducted in both men and women (54.8% female), not exclusively in women. Second, a daily dose of 3.4 to 3.7 minutes of vigorous intermittent lifestyle physical activity (VILPA) was associated with a 17% lower risk of total incident cancer (HR 0.83, 95% CI 0.73-0.93) and a 28% lower risk of physical activity-related cancer (HR 0.72, 95% CI 0.59-0.88), not a 40% reduction. Reductions near 30-40% were only observed for physical activity-related cancers at higher doses (e.g., around 4.5 or more minutes per day), and the observational design cannot establish causality.

2:33:00Rhonda Patrickoverstatedlow

Tapering down the dose of GLP-1 drugs helps slow weight regain compared to stopping all at once.

"If you want to stop and get off it, you have a better chance of success if you taper down the dose and and don't just full stop, you know, get off of it. Um, it seems like tapering down helps people at least slow the weight regain where it's not happening all of a sudden." (said at 2:33:00)

While reduced-intensity or lower-dose maintenance therapy attenuates weight regain as long as medication continues, there is currently no prospective clinical trial evidence demonstrating that tapering down the dose prior to complete discontinuation slows or reduces weight regain compared to stopping abruptly once the medication is entirely discontinued. Major clinical trials (such as STEP-4 and SURMOUNT-4) tested abrupt withdrawal to placebo and found substantial weight regain, and current medical reviews emphasize that structured tapering protocols to successfully facilitate discontinuation remain unvalidated.

2:33:25Rhonda Patrickoverstatedmoderate

Intermittent fasting can achieve a similar 5% to 10% body weight loss as the lowest dose of GLP-1 drugs like Ozempic.

"Intermittent fasting is so on the lowest dose of some of these drugs like Ozempic for example if you're on the lowest dose you can achieve a similar amount of weight loss from intermittent fasting as you do from that and it's not you know if it's five five you know 5 to 10% body weight" (said at 2:33:25)

The claim is overstated. Systematic reviews and meta-analyses of randomized controlled trials demonstrate that intermittent fasting typically leads to modest weight loss (averaging ~2.8 kg or ~3% to 4% of initial body weight), which is equivalent to standard continuous caloric restriction rather than producing a consistent 5% to 10% reduction. In contrast, lower clinical maintenance doses of semaglutide (0.5 mg to 1.0 mg) reliably achieve average weight reductions between 7% and 10% in clinical studies.

2:35:25Rhonda Patrickoverstatedlow

An omega-3 index in the 8% range is associated with a 5-year increased life expectancy.

"8% range is the 5-year increased life expectancy." (said at 2:35:25)

The claim refers to findings from prospective cohort studies such as the Framingham Heart Study Offspring cohort (McBurney et al., 2021; Harris et al., 2018), where a higher Omega-3 Index (e.g., >6.8% vs. <4.2%) was associated with significantly reduced all-cause mortality (approximately 34% lower risk), comparable in predictive magnitude to regular smoking vs. non-smoking (~4.7 to 5 years of estimated remaining life expectancy difference in epidemiological modeling). However, asserting directly that an Omega-3 Index in the 8% range provides or is associated with a definitive '5-year increased life expectancy' overstates observational predictive modeling as a proven causal life expectancy extension.

2:35:28Rhonda Patrickoverstatedlow

An omega-3 index in the 8% range is associated with a 66% lower risk of dementia.

"It's the, you know, 66% lower dementia risk." (said at 2:35:28)

Observational cohort data (such as from the Framingham Offspring Cohort) show that higher red blood cell (RBC) DHA levels are significantly associated with a lower risk of dementia and Alzheimer's disease (AD). However, the observed relative risk reduction was 49% for incident AD comparing the highest quintile to the lowest quintile (HR 0.51, 95% CI: 0.27-0.96), and prior Framingham analyses showed a 47% reduction for all-cause dementia (HR 0.53, 95% CI: 0.29-0.97). Citing a '66% lower risk' overstates the magnitude of the association found in published prospective cohorts.

12 Needs context
0:00:57Rhonda Patrickneeds contextmoderate

Muscle mass and bone density peak around age 25 and steadily decline thereafter.

"For example, muscle mass, bone density, that kind of peaks around 25 years old, and then they kind of steadily start to decline." (said at 0:00:57)

The claim is an approximate simplification of human physiological development. Peak bone mineral density (BMD) is generally attained in young adulthood (between late adolescence and the late 20s or early 30s, depending on sex, ethnicity, and skeletal site). For instance, femoral neck BMD peaks earlier (late teens to mid-20s), whereas lumbar spine and total body BMD often peak in the late 20s to mid-30s. Similarly, peak skeletal muscle mass is reached in young adulthood to early mid-life; however, clinically significant, steady muscle mass loss (sarcopenia) typically becomes noticeable after age 40 to 50 rather than immediately dropping in the late 20s.

0:18:03Rhonda Patrickneeds contextmoderate

Eating a large meal fewer than three hours before bed activates the sympathetic nervous system and disrupts sleep quality.

"So, you want to stop eating 3 hours before bed. And three is really the magic number in multiple studies, because when you eat a meal, it is activating your sympathetic nervous system, right? That's the fight-or-flight response. That's not what you want active when you're about to go to bed." (said at 0:18:03)

Meal ingestion triggers postprandial autonomic, cardiovascular, and metabolic changes—including sympathetic nervous system activation and diet-induced thermogenesis. Randomized crossover trials and chrononutrition studies confirm that eating close to bedtime (typically within 1 to 3 hours) impairs sleep quality, reduces sleep efficiency, and increases nocturnal awakenings and arousal indices compared to earlier meals. While evidence supports avoiding large meals in the late evening, the specific '3 hours' threshold serves as a standard clinical guideline and rule of thumb rather than an absolute biological cutoff established across all trials.

0:28:40Rhonda Patrickneeds contextlow

Ketone bodies increase the level of the inhibitory neurotransmitter GABA in the brain.

"And I feel less anxious, which is part of it because those ketones also help increase something called GABA. That's an inhibitory neurotransmitter. It's essentially, you can just think of it as like it helps you feel calmer." (said at 0:28:40)

The claim that ketone bodies increase brain GABA (an inhibitory neurotransmitter associated with calming/anxiolytic effects) reflects a prominent mechanistic hypothesis often cited in epilepsy and metabolic psychiatry research. Preclinical animal studies and narrative reviews demonstrate that ketosis can promote glutamic acid decarboxylase (GAD) expression and enhance glutamate-to-GABA synthesis in the brain. However, human evidence is mixed and highly context-dependent. While small pilot studies of ketogenic diets in epilepsy showed increases in brain GABA levels in some patients, an acute human randomized trial administering oral beta-hydroxybutyrate (D-βHB) found that cortical levels of both GABA and glutamate were acutely decreased on 7T MRS rather than increased. Thus, while ketones can modulate GABAergic tone and synthesis pathways, stating unconditionally that ketone bodies increase brain GABA requires substantial nuance.

0:31:36Rhonda Patrickneeds contextmoderate

Exercising in a fasted state enhances fat oxidation both during exercise and throughout the day.

"And so if you're fasted, you get better at burning the fat and oxidizing the fat and you continue to do that throughout the day better as well." (said at 0:31:36)

A systematic review and meta-analysis of 27 studies confirms that performing aerobic exercise in a fasted state increases fat oxidation during the exercise bout compared with performing exercise in a fed state. Acute 24-hour metabolic chamber studies similarly indicate that morning fasted exercise can produce a higher 24-hour cumulative fat oxidation or more negative 24-hour fat balance than fed exercise under controlled energy intake. However, the absolute acute difference in fat oxidation is modest (a few grams), and long-term training trials generally show that exercising fasted versus fed does not result in significantly greater chronic body composition changes or total body fat loss when total daily energy intake and expenditure are matched.

0:36:58Steven Bartlett (host)needs contextlow

Perimenopause is associated with an 8 to 10% annual increase in visceral fat.

"when we think about perimenopause, it usually starts in mid-40s, which is the age range you're in. This is where the eight to 10% annual visceral fat increase begins." (said at 0:36:58)

Perimenopause and the menopausal transition are well documented to involve accelerated fat redistribution toward central and visceral depots (visceral adipose tissue, VAT) independent of chronological age. Longitudinal cohort studies of the menopausal transition (such as the Study of Women's Health Across the Nation, SWAN) confirm a significant, accelerated rate of visceral fat accumulation beginning in perimenopause, with published estimates of visceral fat growth rates often quoted around 6% to 10% per year during this transition window. However, this rate varies substantially across individuals depending on baseline adiposity, ethnicity, physical activity, and exact stage of transition, rather than being a fixed 8–10% annual increase for all women.

0:46:05Rhonda Patrickneeds contextlow

High exposure to BPA and phthalates reduces sperm count, sperm motility, and normal sperm morphology.

"And this is like it's affecting not only just the testosterone, but it's affecting sperm quality. So the shape of the sperm wasn't good. It's affecting the number. So sperm count is down if they're higher BPA or higher phthalates. And also motility, the ability to swim." (said at 0:46:05)

Epidemiological systematic reviews and meta-analyses broadly support an inverse association between exposure to bisphenol A (BPA) and specific phthalate metabolites and semen parameters, particularly sperm count and concentration. However, evidence for reductions in sperm motility and normal morphology is less consistent across compounds and studies. For BPA, meta-analyses show statistically significant reductions in sperm concentration and total count, but effects on motility are weak or non-significant after adjusting for publication bias. For phthalates, specific metabolites (e.g., MBP, MBzP, DEHP) correlate with decreased sperm concentration, but associations with motility and morphology vary widely by metabolite. Furthermore, the evidence base relies primarily on cross-sectional observational studies.

0:49:05Rhonda Patrickneeds contextmoderate

Broccoli sprouts contain 100 times more sulforaphane than mature broccoli.

"Broccoli sprouts have a hundred times more sulforaphane than mature broccoli" (said at 0:49:05)

The claim is based on landmark research by Fahey et al. (PNAS, 1997), which found that 3-day-old broccoli sprouts contain 10 to 100 times higher concentrations of glucoraphanin (the glucosinolate precursor converted into sulforaphane by myrosinase) compared to mature broccoli plants. While the upper end of the measured range reaches 100-fold, typical concentrations vary across cultivars (ranging from 10- to 100-fold), and intact sprouts contain glucoraphanin rather than free sulforaphane itself until enzymatic hydrolysis occurs.

0:58:29Rhonda Patrickneeds contextmoderate

Studies have found higher concentrations of microplastics in glass bottled water than in plastic bottled water due to plastic polymers in bottle cap paint shedding into the water.

"So, the paint that's on these lids, plastic polymers are used in that. And during the processing and, you know, bottling up of these things, they get into the the water. And so, believe it or not, glass bottled water has more microplastics than plastic bottled water." (said at 0:58:29)

Several analytical studies have indeed found higher microplastic concentrations in glass-bottled water compared to single-use plastic (PET) bottled water, identifying polymer coatings, paints, and lubricants on metal/plastic bottle caps as primary shedding sources during capping and abrasion. However, the blanket claim that glass bottles contain more microplastics than plastic bottles requires qualification: returnable/reusable plastic bottles consistently show the highest microplastic concentrations among all packaging types, and findings across brands vary substantially depending on cap design, opening mechanisms, and particle size detection limits.

1:12:24Rhonda Patrickneeds contexthigh

In older adults aged 65 and older, taking a daily Centrum Silver multivitamin for three years reversed global brain aging by 2.1 years and episodic memory aging by almost 5 years.

"men and women that were older adults, they were 65 years and older, they took one Centrum Silver a day... And after three years, they had reversed their brain aging, global brain aging, by 2.1 years, and they reversed their episodic brain aging by almost five years." (said at 1:12:24)

The claim accurately reflects findings from the COSMOS randomized clinical trials (specifically COSMOS-Mind and the meta-analysis of the COSMOS cognitive substudies), where daily Centrum Silver multivitamin-mineral supplementation over 3 years improved global cognition and episodic memory performance by the statistical equivalent of approximately 2 years of global cognitive aging and several years of episodic memory decline. However, 'context' is warranted because the studies measured age-related cognitive test performance (standardized neuropsychological test scores compared against cross-sectional age-related decline), not literal biological reversal of brain aging or structural brain changes.

1:18:04Rhonda Patrickneeds contextlow

Individuals with a high omega-3 index have a five-year increased life expectancy compared to those with a low omega-3 index.

"if you have a high omega-3 index, you have a five-year increased life expectancy compared to low omega-3 index." (said at 1:18:04)

The claim reflects findings from an observational study of the Framingham Offspring Cohort (Sala-Vila et al., 2021; PMID 34134132), where statistical modeling estimated that individuals with a high omega-3 index survived approximately 4.7 to 5 years longer than those with a low index (an effect size similar in magnitude to the mortality difference between non-smokers and smokers). In earlier analyses of the same cohort (PMID 29559306), participants in the highest omega-3 index quintile had a 34% lower risk of all-cause mortality compared to the lowest quintile. However, this is an observational association derived from a single cohort model, not a proven causal increase in lifespan demonstrated in randomized clinical trials.

1:33:10Rhonda Patrickneeds contextmoderate

Phytosomal delivery improves the bioavailability of curcumin by slowing its rapid hepatic clearance and metabolism.

"Phytosomal curcumin—the reason I take phytosomal, it's kind of like a liposome, but it's phytosome. So it's essentially just making the ingredient get into the cells better. It's more bioavailable because curcumin is easily metabolized quickly by the liver. It's what's called a xenobiotic... The phytosomal delivery of it kind of slows that whole process where it's not getting rid of it so quickly, it's not being metabolized so readily." (said at 1:33:10)

Phytosomal curcumin (curcumin complexed with phospholipids such as phosphatidylcholine) substantially improves the oral bioavailability and cellular absorption of curcumin. However, the speaker mischaracterizes the primary mechanism: phytosomes enhance bioavailability primarily by improving aqueous solubility, bioaccessibility, and passive permeability across the intestinal epithelium due to their amphiphilic phospholipid matrix, rather than by inhibiting or slowing hepatic clearance and phase II metabolic enzymes (a mechanism more characteristic of adjuvants like piperine).

2:05:44Rhonda Patrickneeds contextlow

Data indicates an increased risk signal for kidney cancer associated with GLP-1 receptor agonist medications.

"cancer risk goes down. Um, except for one type of cancer goes up, kidney cancer... Kidney cancer is another one. It seems like there's an increased signal for kidney cancer." (said at 2:05:44)

The speaker is referring to findings from a widely cited 2024 retrospective cohort study of 1.6 million patients with type 2 diabetes (Wang et al., JAMA Network Open), which observed an increased risk signal for kidney cancer when GLP-1 receptor agonists (GLP-1RAs) were compared specifically against metformin (HR 1.54, 95% CI 1.27–1.87). However, this finding requires important context: in the same study, GLP-1RAs were associated with a reduced risk of kidney cancer compared with insulin (HR 0.76, 95% CI 0.64–0.91). Furthermore, broader systematic reviews and meta-analyses of clinical trials and cohort studies have found no overall increased risk of renal malignancies with GLP-1RAs compared to general control populations.

73 Supported by research
0:00:24Rhonda Patricksupportedhigh

Heating plastic causes it to leach into food.

"Heating it up. The plastic is getting into your food." (said at 0:00:24)

Extensive analytical chemistry research and comprehensive reviews establish that heating plastic food-contact materials (via microwave or conventional heating) accelerates the migration and leaching of chemical additives (such as plasticizers, phthalates, bisphenols, antioxidants, and degradation products) and micro/nanoparticles into food and food simulants.

0:01:47Rhonda Patricksupportedmoderate

Exercising 5 hours per week including high-intensity interval training can reverse cardiac aging by 20 years.

"Like if you exercise 5 hours a week, do some high-intensity interval training in there, and you can reverse heart aging by 20 years." (said at 0:01:47)

The claim references a landmark 2-year randomized controlled trial led by Dr. Benjamin Levine and Dr. Erin Howden (PMID: 29311053). In the trial, sedentary middle-aged adults (mean age 53 years) undertook a 2-year progressive exercise regimen totaling 4 to 5 sessions (around 5 hours) per week—which included a 4x4 high-intensity interval training (HIIT) session, moderate-intensity sessions, and strength training. The intervention significantly decreased left ventricular (LV) myocardial stiffness (from 0.072 to 0.051) and increased VO2 max by 18%, effectively reversing the age-related cardiac stiffening and remodeling caused by decades of sedentary aging to levels comparable to younger, fitter individuals.

  • supports: Reversing the Cardiac Effects of Sedentary Aging in Middle Age-A Randomized Controlled Tri… (Circulation 2018) · cited 217x in the literature
    "In a prospective, parallel group, randomized controlled trial, we examined the effect of 2 years of supervised high-intensity exercise training on LV stiffness. Sixty-one (48% male) healthy, sedentary, middle-aged participants (53±5 years) were randomly assigned to either 2 years of exercise training (n=34) or attention control (control; n=27)... In previously sedentary healthy middle-aged adults, 2 years of exercise training improved maximal oxygen uptake and decreased cardiac stiffness. Regular exercise training may provide protection against the future risk of heart failure with a preserved ejection fraction by preventing the increase in cardiac stiffness attributable to sedentary aging." (abstract, methods and conclusions, passage verified)
    pubmedfull study (doi)
0:05:11Rhonda Patricksupportedlow

Having high visceral fat doubles the risk of early mortality.

"This visceral fat, for one, it's going to double your risk of early mortality. Full stop. It's going to double your risk." (said at 0:05:11)

Observational cohort studies evaluating visceral adipose tissue (measured via computed tomography or DXA) consistently link elevated visceral adiposity with substantially increased all-cause and cardiometabolic mortality. In multivariable models, high visceral fat depots or top percentiles/SD increases are associated with roughly a 1.7- to 2.0-fold increased risk of all-cause mortality (and up to nearly 3-fold for cardiometabolic mortality), aligning with the speaker's claim of roughly doubling mortality risk.

0:12:36Rhonda Patricksupportedhigh

Estrogen directs the body to store fat subcutaneously in adipose tissue rather than viscerally.

"Women are very susceptible as they go through perimenopause and menopause because estrogen actually helps tell the body how to store energy, and it tells it to store energy and fat in adipose tissue, not viscerally." (said at 0:12:36)

Extensive physiological and clinical evidence supports the claim that estrogens promote lipid storage in subcutaneous adipose tissue depots (a gynoid pattern) while inhibiting visceral fat accumulation. During the menopausal transition, the drop in circulating estrogen levels shifts fat distribution toward increased visceral/intra-abdominal adipose accumulation, an effect that is reversed or attenuated by estrogen-based menopausal hormone therapy.

  • supports: The sexual dimorphism of obesity. (Molecular and cellular endocrinology 2015) · cited 929x in the literature
    "females accrue more fat in the subcutaneous depot prior to menopause, a feature which affords protection from the negative consequences associated with obesity and the metabolic syndrome. After menopause, fat deposition and accrual shift to favor the visceral depot. ... Evidence suggests that estrogens augment the sympathetic tone differentially to the adipose tissue depots favoring lipid accumulation in the subcutaneous depot in women and visceral fat deposition in men. At the level of adipocyte function, estrogens and their receptors influence the expandability of fat cells enhancing the expandability in the subcutaneous depot and inhibiting it in the visceral depot." (abstract, passage verified)
    pubmedfull study (doi)
  • supports: Metabolic and Epigenetic Regulation by Estrogen in Adipocytes. (Frontiers in endocrinology 2022) · cited 98x in the literature
    "Higher concentrations of estrogens are associated with a more gynoid body shape and with more fat storage on hips and thighs rather than in visceral depots. Estrogen-mediated protection against visceral adiposity is shown in post-menopausal women with lower levels of estrogens and the reduction in central body fat observed after treatment with hormone-replacement therapy." (abstract, passage verified)
    pubmedfull study (doi)
  • supports: Roles of estrogens, estrogen-like compounds, and endocrine disruptors in adipocytes. (Frontiers in endocrinology 2022) · cited 35x in the literature
    "While androgens tend to accumulate fat in the splanchnic and the visceral region with an increase in cardiovascular risk, estrogens generate more subcutaneous and extremity distribution of adipose tissue. The absence of estrogen during menopause seems to be the main factor that gives rise to the greater predisposition of women to suffer cardiovascular alterations." (abstract, passage verified)
    pubmedfull study (doi)
0:19:44Rhonda Patricksupportedmoderate

Cooking a starchy food like a potato or rice, letting it cool, and then eating it increases resistant starch, which benefits the gut microbiome and improves sleep.

"Maybe not a fried potato, baked potato, and then cool it, because then it's resistant starch, right? Because then it's good for your gut microbiome... It changes the composition of the fiber, and you can cook it, let it cool, and then heat it again if you like to eat it heated, as long as it went through a cooling part." (said at 0:19:44)

Cooking and then cooling starchy foods such as potatoes promotes starch retrogradation, forming type 3 resistant starch (RS-3). This retrograded starch resists upper gastrointestinal digestion, enters the large intestine intact, and serves as a fermentable substrate for key gut bacteria (such as Ruminococcus bromii). Randomized trial data in humans confirm that cooled potatoes contain higher amounts of resistant starch (e.g., 13.7 g vs. 9.2 g per 250 g serving) compared to freshly cooked hot potatoes.

0:26:48Rhonda Patricksupportedmoderate

It takes approximately 10 to 12 hours of fasting for the liver to deplete glycogen stores and initiate the metabolic switch to ketosis.

"And it takes about 10 to 12 hours for your liver to deplete glycogen. Glucose that's been taken up by the liver is stored as glycogen so that you can then use it for energy later if you don't have energy coming in." (said at 0:26:48)

Human metabolic physiology literature indicates that the onset of the metabolic switch—the point where liver glycogen stores are substantially depleted and metabolism shifts toward fatty acid oxidation and ketone production—typically begins beyond 12 hours of fasting (Anton et al., 2018). While complete exhaustion of hepatic glycogen can extend up to 24 to 48 hours depending on basal metabolic rate and physical activity (Cherrington, 2007), the 10- to 12-hour window accurately reflects the established threshold for glycogen depletion driving the initiation of the metabolic switch.

0:29:55Rhonda Patricksupportedmoderate

Aerobic endurance training performed in a fasted state yields greater training adaptations compared to training in a fed state.

"But there are studies, multiple studies showing that if you do aerobic endurance training, this kind of running, cycling, swimming type of training, you actually have better adaptations if you're fasted versus fed." (said at 0:29:55)

Multiple randomized studies demonstrate that aerobic endurance training performed in the overnight-fasted state enhances specific skeletal muscle and metabolic adaptations compared to training in the fed state. In randomized training interventions, fasted endurance exercise elicited greater increases in muscle oxidative enzyme activity (e.g., citrate synthase and β-hydroxyacyl-CoA dehydrogenase), greater improvements in maximal fat oxidation rates, enhanced intramyocellular lipid breakdown, and in some trials greater gains in VO2max and basal glycogen storage compared to carbohydrate-fed training.

0:04:41Steven Bartlett (host)supportedmoderate

Average visceral fat increases with age, measuring roughly 1.2 pounds in men and 0.5 pounds in women at age 30, 1.7 pounds in men and 0.7 pounds in women at age 40, 2.2 pounds in men and 1.0 pound in women at age 50, and 2.7 pounds in men and 1.54 pounds in women at age 60.

"According to the data, it says roughly 1.2 lb at the age of 30, and then for a woman, 0.5 lb of visceral fat at the age of 30. At 40, it's 1.7 lb for a man and 0.7 for a woman. At 50, 2.2 lb for a man, 1 lb for a woman. And at 60, 2.7 lb of visceral fat and 1.54 lb for a woman, which is the highest risk for metabolic syndromes at that age." (said at 0:04:41)

Dual-energy X-ray absorptiometry (DXA) normative reference datasets (such as GE Lunar and Hologic population reference curves) show that visceral adipose tissue (VAT) increases progressively with age and is consistently higher in men than in women across adulthood. The specific values cited by the host (ranging from approximately 1.2 to 2.7 lbs [~0.5-1.2 kg] for men and 0.5 to 1.54 lbs [~0.2-0.7 kg] for women between ages 30 and 60) match established 50th-percentile (median/mean) reference trajectories for general adult populations.

0:22:29Rhonda Patricksupportedhigh

Physical activity stimulates glucose transporters and allows muscles to take up glucose directly without requiring insulin.

"Physical activity makes your muscles very responsive to glucose without needing insulin. The transporters that transport glucose are super, super responsive when you exercise." (said at 0:22:29)

The claim accurately describes a canonical physiological mechanism of skeletal muscle glucose uptake. Muscle contraction and physical activity stimulate the translocation of the glucose transporter type 4 (GLUT4) to the plasma membrane via an insulin-independent intracellular signaling pathway (involving AMPK, calcium release, and other mechanical signals), allowing muscle tissue to take up glucose directly from the bloodstream without requiring insulin stimulation.

0:32:21Rhonda Patricksupportedhigh

Exercise stimulates the production of new mitochondria.

"And so exercise does make you increase the amount of those new mitochondria that you make that are young and healthy." (said at 0:32:21)

A large body of clinical and trial evidence demonstrates that exercise (both continuous endurance and interval training) stimulates mitochondrial biogenesis in skeletal muscle. Systematic reviews and meta-analyses show significant exercise-induced upregulation of key biogenesis regulators such as PGC-1α alongside increases in mitochondrial volume density, citrate synthase activity, and mitochondrial quality control pathways (mitophagy and mitochondrial turnover).

0:33:32Rhonda Patricksupportedhigh

In women, high-volume exercise combined with severe caloric deficit disrupts follicle-stimulating hormone and luteinizing hormone, leading to amenorrhea and cessation of ovulation.

"Now, the problem with women is that if you're in too much of a caloric deficit and you don't eat enough food afterwards, you're not refueling enough and you're doing very long, high-volume types of exercise, then you can basically disrupt some of your hormones, your follicle-stimulating hormone, luteinizing hormone. These things will make you become amenorrheic. So you basically stop ovulating and you stop getting your menstrual period." (said at 0:33:32)

The speaker accurately describes the physiology of exercise-associated functional hypothalamic amenorrhea (part of the Relative Energy Deficiency in Sport/RED-S and the Female Athlete Triad models). When high exercise energy expenditure is combined with inadequate caloric intake (low energy availability), suppression of hypothalamic GnRH secretion alters LH and FSH pulsatility and secretion, leading to anovulation and secondary amenorrhea.

0:35:40Steven Bartlett (host)supportedmoderate

The SWAN study found that women experience an accelerated increase in visceral fat starting two years prior to their final menstrual period.

"the SWAN study, which kind of relates to what you just said there when relating to women in visceral fat, and they found that women experience an accelerated increase in visceral fat starting two years before their final menstrual period." (said at 0:35:40)

A longitudinal analysis of 362 midlife women from the Study of Women's Health Across the Nation (SWAN) Heart study evaluated visceral adipose tissue (VAT) trajectories relative to the final menstrual period (FMP). Spline modeling identified that VAT accumulation accelerated markedly starting 2 years prior to the FMP (increasing by 8.2% per year from 2 years pre-FMP to FMP, compared to no significant increase more than 2 years prior to the FMP).

0:36:05Rhonda Patricksupportedmoderate

The average age of natural menopause in women is between 50 and 52 years.

"Average age of menopause is between about 50 to 52 for women." (said at 0:36:05)

Epidemiological data and population-based surveys consistently show that the average and median age of natural menopause in Western populations is approximately 50 to 52 years (e.g., NHANES analysis demonstrates a median age of natural menopause of 50 years and a mean of ~49.5 years). Global meta-analyses show regional variability ranging from roughly 46 to 52 years depending on country, socioeconomic status, and lifestyle factors.

0:36:14Rhonda Patricksupportedmoderate

A younger age at menarche is associated with a younger age at menopause.

"So the younger you were, the younger you're going to be when you experienced menopause." (said at 0:36:14)

Large pooled observational cohort studies and meta-analyses show that an earlier age at menarche (such as ≤11 years) is significantly associated with an earlier onset of natural menopause and an increased risk of premature (before age 40) and early (ages 40-44) menopause.

0:36:21Rhonda Patricksupportedmoderate

Maternal age at menopause is a strong predictor of a woman's age of menopause onset.

"Also when your mother experienced menopause is very indicative of when you're going to experience it." (said at 0:36:21)

Epidemiological cohort and family studies confirm that maternal age at natural menopause is a significant predictor of a daughter's menopausal timing, with heritability estimates ranging between 44% and 52%. Large multigenerational cohort analyses (such as the Framingham Heart Study) and prospective studies demonstrate a significant mother-daughter correlation (r ~ 0.21) and show that maternal menopausal age significantly informs models predicting a daughter's time to menopause, as well as the rate of decline in ovarian reserve markers.

0:36:35Rhonda Patricksupportedlow

Endocrine-disrupting chemicals can accelerate the onset of menopause by up to two years.

"A lot of these endocrine-disrupting chemicals affect the age of menopause as well and accelerate that. So in some cases women go into menopause two years earlier than they would have otherwise." (said at 0:36:35)

A landmark cross-sectional analysis of National Health and Nutrition Examination Survey (NHANES 1999–2008) data evaluating 111 endocrine-disrupting chemicals (EDCs) found that women with the highest serum or urine concentrations of 15 specific EDCs (including certain phthalate metabolites, PCBs, and persistent pesticides) reached natural menopause an average of 1.9 to 3.8 years earlier than women with lower exposure levels. Subsequent narrative and systematic reviews corroborate that environmental EDC exposures are associated with accelerated ovarian aging and earlier menopausal timing, although the certainty is low due to the observational and cross-sectional nature of the primary epidemiological data.

0:39:06Steven Bartlett (host)supportedmoderate

Starting at age 30, testosterone levels in men decline by roughly 1% per year.

"And starting at age 30, testosterone drops roughly 1% a year." (said at 0:39:06)

Large longitudinal cohort studies (such as the Massachusetts Male Aging Study and the Baltimore Longitudinal Study of Aging) demonstrate that circulating total testosterone levels decline at an average rate of approximately 0.8% to 1.6% per year (with bioavailable and free testosterone dropping by roughly 2% per year) beginning in early-to-mid adulthood (commonly cited around age 30 to 40).

0:41:23Steven Bartlett (host)supportedmoderate

Average testosterone levels in men have decreased by up to 20% over the last two decades.

"testosterone levels in men have dropped by up to 20% over the last two decades, which is quite terrifying." (said at 0:41:23)

Several large population-based cohort and cross-sectional studies have documented secular (age-independent) declines in male serum testosterone levels over recent decades. In the Massachusetts Male Aging Study (MMAS), Travison et al. (2007) found an age-independent population-level decline in total testosterone of approximately 1% per calendar year between 1987-1989 and 2002-2004, which corresponds to an estimated ~15% to 20% drop over a 15- to 20-year period. Similar birth-cohort and secular declines have been reported in Danish and Finnish population studies.

0:41:41Rhonda Patricksupportedmoderate

Zinc and magnesium are essential micronutrients for testosterone synthesis.

"micronutrients, not getting enough zinc, for example—zinc's very important for testosterone synthesis—and magnesium." (said at 0:41:41)

Zinc and magnesium play established roles in testosterone biosynthesis and regulation. Zinc is a critical trace element for Leydig cell function, where its deficiency downregulates key steroidogenic enzymes (such as StAR, P450scc, and 3beta-HSD) and leads to significant reductions in circulating testosterone in human dietary-restriction trials (Prasad et al., 1996). Similarly, magnesium status and supplementation have been shown to modulate steroidogenic enzyme activity and increase free and total testosterone levels in both sedentary individuals and athletes.

0:43:53Rhonda Patricksupportedmoderate

High exposure to PFAS chemicals is associated with women reaching menopause one to two years earlier.

"so the PFAS chemicals are ones that really are more affecting the thyroid and they're affecting, I would say, ovarian aging. They seem to target the ovaries and accelerate the age that you're going to get menopause, so you're going to get it around one to two years earlier if you have a high amount of these forever chemicals." (said at 0:43:53)

The claim closely matches findings from prospective cohort research. In the Study of Women's Health Across the Nation (SWAN; PMID 32491182), baseline serum concentrations of PFAS mixtures were prospectively evaluated in 1,120 premenopausal women over nearly two decades. Women in the highest PFAS exposure cluster had a significantly higher hazard of natural menopause (HR 1.63, 95% CI: 1.08–2.45), corresponding to reaching natural menopause approximately 2.0 years earlier compared to the lowest exposure group. Other individual PFAS (such as n-PFOS and n-PFOA) were also associated with increased hazard ratios for earlier menopause.

0:44:22Rhonda Patricksupportedmoderate

BPS is an endocrine disruptor that is very similar to or worse than BPA.

"Well, it's BPA-free, but it has another chemical called BPS, which is very similar, if not worse, than BPA." (said at 0:44:22)

The speaker claimed that BPA-free products often contain bisphenol S (BPS), which is an endocrine disruptor very similar to or potentially worse than bisphenol A (BPA). Systematic reviews and toxicological assessments confirm that BPS was widely introduced as a BPA replacement in 'BPA-free' products, and exhibits comparable endocrine-disrupting potencies (estrogenic, antiestrogenic, androgenic, and antiandrogenic actions in the same order of magnitude in vitro and in vivo), with some non-genomic and cellular signaling endpoints showing equal or higher potency.

0:45:58Rhonda Patricksupportedlow

A study in men found that those with the highest phthalate levels had 20% lower testosterone compared to men with lower levels.

"So, there was a study in men that had the highest phthalate levels, those men had 20% lower testosterone compared to men with lower levels." (said at 0:45:58)

A representative cross-sectional study of the US population using NHANES 2011–2012 data (Ferguson et al., 2014) evaluated urinary phthalate metabolites and serum total testosterone levels across sexes and age groups. In adult men aged 40–60 years, higher concentrations of phthalate metabolites (specifically di-2-ethylhexyl phthalate and dibutyl phthalate) were associated with significant reductions in testosterone levels (with effect sizes ranging from ~20% to over 30% reduction across exposure ranges). Because the finding comes from cross-sectional observational data, certainty for causality is low.

0:47:38Rhonda Patricksupportedlow

Bisphenol A (BPA) inhibits the enzyme aromatase, which converts testosterone into estrogen.

"And this is very important because it's disrupting aromatase as well, that enzyme that's involved in converting testosterone into estrogen... And so when you have aromatase being inhibited by bisphenol A" (said at 0:47:38)

The speaker's statement is supported by biochemical, cellular, and animal evidence. Aromatase (encoded by the CYP19A1 gene) is the cytochrome P450 enzyme responsible for the aromatization of androgens (including testosterone) into estrogens. Multiple in vitro and animal studies demonstrate that bisphenol A (BPA) can act as an endocrine-disrupting inhibitor of aromatase enzymatic activity and downregulate CYP19A1 expression.

0:48:33Rhonda Patricksupportedmoderate

Consuming canned soup has been shown in studies to increase urinary BPA levels by 1,000%.

"the soup has been classically shown in multiple studies to increase BPA levels by 1,000%. Crazy amounts. So, don't eat canned soup." (said at 0:48:33)

The claim is supported by a landmark randomized crossover trial led by Harvard researchers (Carwile et al., JAMA 2011, PMID: 22110104), which found that consuming one serving per day of canned soup for 5 days resulted in a 1,221% increase in urinary bisphenol A (BPA) concentrations compared to consuming fresh soup. Observational data from NHANES (PMID: 27362993) also confirmed that canned soup consumption is associated with substantial elevations in urinary BPA (a 229% increase).

0:55:43Rhonda Patricksupportedmoderate

Black plastic used in food containers is often sourced from recycled electronics containing toxic flame retardants that leach into food.

"it also typically is made from recycled electronics. And the problem here, Steven, is recycled electronics have flame retardants in them because you don't want your electronics catching fire. And there have been a variety of studies now that have found that black plastic has a high amount of these flame retardants that are leaching into the food and getting into people's bodies that way." (said at 0:55:43)

Multiple analytical surveys and migration studies confirm that black plastic consumer items, including food packaging, kitchen utensils, and thermo cups, frequently contain brominated flame retardants (BFRs) and related synergists (such as antimony). These contaminants enter the supply chain primarily when recycled waste electrical and electronic equipment (WEEE) plastics are inappropriately processed into consumer goods. Furthermore, migration testing demonstrates that flame retardants present in contaminated food-contact articles can leach into both food simulants and actual food products (such as hot liquids and fatty foods).

0:59:20Rhonda Patricksupportedlow

Nanoplastics from plastic water bottles penetrate the gut barrier and enter the bloodstream.

"This has tons of what are called nanoplastics, very, very small particles that get into the gut and get into your bloodstream." (said at 0:59:20)

A landmark 2024 study by Qian et al. (PNAS) demonstrated that bottled water contains hundreds of thousands of plastic particles per liter (approximately 2.4 ± 1.3 × 10⁵ particles/L), roughly 90% of which are nanoplastics (<1 μm). Preclinical and in vitro toxicological evidence shows that due to their sub-micron size, nanoplastics can cross the intestinal epithelial barrier via endocytosis and paracellular disruption, translocating into systemic circulation and peripheral organs. Certainty is rated as low because evidence for intestinal translocation and systemic absorption relies predominantly on animal, cellular, and environmental toxicological models rather than direct human pharmacokinetic trials.

0:47:04Rhonda Patricksupportedmoderate

Maternal exposure to high levels of phthalates during pregnancy is linked to abnormal male fetal genital development, specifically hypospadias and undescended testicles (cryptorchidism).

"Pregnant women that get exposed to high levels of phthalates and if they're carrying a male fetus, right, they're having a boy, what's been shown is it's also affecting sexual development. So these boys, they're getting something called hypospadias. That's where the slit on the penis is moved backwards kind of closer to what a woman would have. And they're getting undescended testicles." (said at 0:47:04)

Epidemiological studies and meta-analyses support the link between prenatal phthalate exposure (notably DEHP and DBP) and disrupted male urogenital development, including increased risks of hypospadias and cryptorchidism (undescended testicles). Phthalates act as anti-androgenic endocrine-disrupting chemicals that interfere with fetal androgen production during the critical masculinization programming window.

0:47:40Rhonda Patricksupportedmoderate

Cryptorchidism (undescended testicles) is associated with increased risks of male infertility and testicular cancer.

"And they're getting undescended testicles. So one of their testicles is not descending. And that's associated with infertility, cancer—testicular cancer being the big one." (said at 0:47:40)

Cryptorchidism (undescended testis) is a well-established risk factor for both male infertility and testicular germ cell cancer. Meta-analyses and pediatric urology clinical guidelines consistently demonstrate that individuals with a history of cryptorchidism have an approximately 3- to 4-fold increased relative risk of testicular cancer compared to the general population, as well as significantly higher rates of impaired spermatogenesis and infertility.

0:56:16Rhonda Patricksupportedmoderate

Acidic and heated foods accelerate the leaching of endocrine-disrupting chemicals, such as BPA and phthalates, from plastic containers.

"because spicy foods, anything acidic that goes into plastic causes the chemicals to leach into it even more rapidly, kind of the same way that heat does. So, heat, acidic foods, not good in plastic." (said at 0:56:16)

Extensive food contact material migration research confirms that both elevated temperature and higher acidity (lower pH) significantly accelerate the chemical migration and leaching of endocrine-disrupting chemicals, including phthalates and bisphenol compounds, from plastics into food and beverage matrices.

1:03:47Rhonda Patricksupportedlow

Mechanical friction on plastic blender containers releases orders of magnitude more microplastics into blended food compared to static containers.

"there are studies showing that when you have a lot of friction on plastic, that releases orders of magnitude more microplastics. And of course, their associated chemicals are hitchhiking along there." (said at 1:03:47)

Studies evaluating micro- and nanoplastic shedding from kitchen appliances demonstrate that mechanical agitation and friction dramatically increase particle shedding compared to static storage. Specifically, testing of plastic kitchen blenders demonstrated the release of approximately 0.36 to 0.78 billion micro- and nanoplastics into liquid within just 30 seconds of operation (W4365517416). Systematic evaluations of kitchen equipment confirm that mechanical processes such as blending, chopping, and grinding accelerate plastic degradation and particle detachment relative to passive contact (W4400941889). Certainty is graded as low due to reliance on a limited number of in vitro/laboratory simulation studies.

1:04:22Rhonda Patricksupportedhigh

Thermal paper receipts are coated with bisphenol A (BPA) to facilitate printing.

"receipts are covered with BPA. I mean, literally just covered. That's how it prints it, right? This isn't like a printer. This is printed. It's a thermal paper and the BPA is allowing the printing to happen." (said at 1:04:22)

The speaker's claim is supported. Thermal receipt paper relies on a heat-sensitive coating that typically contains a leuco dye and a developer (most commonly bisphenol A, BPA, or related analogs like BPS). When heat is applied by the thermal print head, the dye and the developer melt together and react, generating the visible dark print without requiring liquid ink or toner.

1:04:27Rhonda Patricksupportedmoderate

Handling thermal receipts with hand sanitizers or creams increases dermal absorption of BPA into the bloodstream about a hundredfold compared to dry hands.

"People that are handling receipts, like cashiers that are handling receipts, have really high levels of BPA, particularly if they use like hand sanitizing lotion or any lotion. Any sort of cream makes the BPA—again, BPA is fat soluble. These creams, the hand sanitizers are carrying it inside to your inside your bloodstream about a hundredfold higher than not having that." (said at 1:04:27)

The claim reflects findings from an experimental human exposure study (PMID 25337790) investigating BPA absorption from thermal receipts. The authors demonstrated that hand sanitizers and lotions containing dermal penetration enhancers can increase the transdermal penetration of lipophilic compounds such as BPA by up to 100-fold. Handling thermal receipts shortly after applying hand sanitizer resulted in rapid transfer to skin and substantial increases in bioactive serum BPA and urinary BPA metabolites.

1:06:48Rhonda Patricksupportedhigh

Reverse osmosis water filters remove microplastics, nanoplastics, BPA, phthalates, and chemical contaminants from water.

"Reverse osmosis water filters filter out microplastics, nanoplastics, BPA, phthalates, chemicals, all these things that we're talking about today." (said at 1:06:48)

Reverse osmosis (RO) membrane filtration effectively removes microplastics, nanoplastics, bisphenol A (BPA), phthalates, and other chemical micropollutants from water. RO membranes operate with pore sizes in the sub-nanometer range (<1 nm), which enables high rejection of particulate contaminants (micro- and nanoplastics) via size exclusion, as well as dissolved endocrine-disrupting chemicals and organic micropollutants through steric hindrance and electrostatic interactions.

1:10:01Rhonda Patricksupportedmoderate

Liposomal encapsulation allows glutathione to fuse with cells and achieve higher bioavailability than standard oral glutathione.

"Liposomal glutathione has been shown to get inside because liposomes—it's essentially taking the glutathione molecule and encapsulating it in something that's going to fuse with your cell. Liposomal products in general have a higher bioavailability for that reason." (said at 1:10:01)

Liposomal encapsulation protects glutathione from gastrointestinal breakdown and facilitates cellular uptake through lipid membrane interactions, yielding superior systemic bioavailability compared to standard oral glutathione. A comparative human pharmacokinetic and in vitro study demonstrated ~1.9-fold higher cellular uptake and roughly 6-fold higher peak plasma concentrations with liposomal glutathione relative to plain glutathione.

1:11:01Rhonda Patricksupportedhigh

Vitamin D2 is less effective at raising vitamin D status than vitamin D3.

"there have been studies showing that vitamin D2, which is unfortunately what a lot of vegetarians take because they want a vegetarian form... vitamin D2 is not as effective as vitamin D3." (said at 1:11:01)

Multiple systematic reviews and meta-analyses of randomized controlled trials confirm that vitamin D3 (cholecalciferol) is significantly more effective at increasing and maintaining total serum 25-hydroxyvitamin D concentrations than vitamin D2 (ergocalciferol), across both bolus and daily dosing regimens.

1:11:41Rhonda Patricksupportedlow

In vitamin D-deficient individuals, supplementing with vitamin D3 slowed biological aging by almost two years, an effect not observed in non-deficient individuals.

"there's actually a recent study showing that people that are vitamin D deficient, so they're not getting enough vitamin D3 because we don't go out in the sun anymore, they have accelerated aging. And if they supplement—this is a very large study, by the way—if they supplemented with vitamin D3, they slowed their biological aging by almost two years. That didn't happen in people that were not vitamin D deficient from the start." (said at 1:11:41)

The speaker accurately references the findings of a 2022 study of the Berlin Aging Study II (BASE-II/GendAge cohort, n=1,036) published in GeroScience. In that longitudinal quasi-interventional study, vitamin D-deficient participants who started supplementation had a 1.3- to 2.6-year lower epigenetic age acceleration compared to untreated deficient participants (roughly two years slower biological aging), whereas successfully treated individuals did not differ from non-deficient controls. Because this is a quasi-interventional/observational cohort study without randomized allocation, certainty is low.

1:13:02Rhonda Patricksupportedhigh

In the COSMOS study, two years of daily multivitamin supplementation slowed epigenetic and biological aging by a few months.

"this same study also just recently published literally like a couple of weeks ago, again part of this large study—it's called the COSMOS study—they looked at the multivitamin use and biological aging, epigenetic aging, and they found that the Centrum Silver multivitamin also slowed biological aging, epigenetic aging, by a few months. And this was only after two years." (said at 1:13:02)

A prespecified ancillary randomized controlled trial from the COcoa Supplement and Multivitamin Outcomes Study (COSMOS) involving 958 older adults evaluated 2 years of daily Centrum Silver supplementation compared with placebo. Daily multivitamin supplementation modestly slowed the progression of second-generation epigenetic clocks, showing a between-group difference in yearly change of -0.113 years for PCGrimAge and -0.214 years for PCPhenoAge (which equates to slowing epigenetic aging by roughly 2.5 to 5 months over 2 years).

  • supports: Effects of daily multivitamin-multimineral and cocoa extract supplementation on epigenetic… (Nature medicine 2026) · cited 18x in the literature
    "This prespecified ancillary study evaluated the 2-year effect of a daily MVM (Centrum Silver) and cocoa extract (500 mg cocoa flavanols per day, including 80 mg (-)-epicatechin) on five DNA methylation measures of biological aging (PCHannum, PCHorvath, PCPhenoAge, PCGrimAge and DunedinPACE) among 958 participants (482 women and 476 men) in the COcoa Supplement and Multivitamin Outcomes Study (COSMOS). Compared with placebo, daily MVM supplementation modestly reduced the rate of increase of second-generation epigenetic clocks, with a between-group difference in yearly change of -0.113 years (95% confidence interval (CI) -0.205 to -0.020; P = 0.017) for PCGrimAge and -0.214 years (-0.410 to -0.019; P = 0.032) for PCPhenoAge." (abstract, results)
    pubmedfull study (doi)
1:17:04Rhonda Patricksupportedmoderate

Approximately 16% of menstruating women are iron deficient.

"premenopausal women do lose a lot of iron from menstruation when they're menstruating. And so I would say about 16% of menstruating women are iron deficient." (said at 1:17:04)

Representative national survey data (such as NHANES) consistently estimate the prevalence of iron deficiency among non-pregnant, reproductive-aged women to be around 16% to 17% (e.g., 8-16% depending on biomarker cutoffs, and ~17.3% using standard serum ferritin thresholds < 15 µg/L).

1:17:50Rhonda Patricksupportedmoderate

90% of the US population and 80% globally do not consume sufficient levels of omega-3 fatty acids.

"Omega-3 fatty acids: 90% of the US population is not getting enough of them, 80% globally, everyone. Nobody's getting enough omega-3 fatty acids, particularly from seafood." (said at 1:17:50)

Large-scale dietary surveys and global biomarker analyses confirm that the vast majority of both the US and global populations fail to meet dietary recommendations or optimal blood levels for marine omega-3 fatty acids (EPA and DHA). In US analyses (NHANES), over 90–95% of individuals fail to meet the Dietary Guidelines recommendation of 250 mg/day of EPA+DHA or 8 ounces of seafood per week. Globally, systematic mapping of EPA+DHA blood levels shows that most countries and regions fall into the 'low' to 'very low' blood status categories, with only a few countries (e.g., Japan, Scandinavia) achieving high blood levels.

1:18:10Rhonda Patricksupportedlow

Smokers with a high omega-3 index have the same life expectancy as non-smokers with a low omega-3 index.

"If you're a smoker and you have a high omega-3 index, then you're going to live as long as a non-smoker with a low omega-3 index, right? I mean, so the low omega-3 index is like smoking, basically." (said at 1:18:10)

The speaker is referencing a 2021 study by McBurney et al. analyzing 2,240 participants from the Framingham Offspring Cohort followed for 11 years (PMID: 34134132). In their statistical modeling of all-cause mortality, individuals who smoked but had a high Omega-3 Index (O3I) had predicted survival trajectories comparable to non-smokers with a low Omega-3 Index, leading the authors to note that having a low O3I carried a risk magnitude similar to smoking in this cohort. Because this finding is based on an observational cohort model in adults in their mid-60s rather than an interventional trial proving causation, the certainty of evidence is low.

1:22:25Rhonda Patricksupportedhigh

Daily supplementation of 5 grams of creatine monohydrate saturates skeletal muscle stores within 3 to 4 weeks without a loading phase.

"If you're not about to compete and if you haven't been using creatine and you're not participating in the study, it takes about three to four weeks of 5 grams a day consistently to saturate your muscle. So you don't have to do any loading phase." (said at 1:22:25)

The claim is supported by clinical trial data and sports nutrition consensus. The landmark trial by Hultman et al. (1996) demonstrated that daily supplementation of 3 g/day (or standard 3–5 g/day dosing) leads to an equivalent ~20% increase in total skeletal muscle creatine content over 28 days (4 weeks) compared to a traditional rapid loading protocol (20 g/day for 6 days), confirming that a loading phase is not required to reach muscle saturation.

1:27:16Rhonda Patricksupportedmoderate

Approximately 50% of the population does not consume sufficient dietary magnesium.

"50% of the population doesn't get enough magnesium. And I bet you're probably one of those people, because most of us are." (said at 1:27:16)

Nationally representative dietary survey data from the National Health and Nutrition Examination Survey (NHANES) consistently demonstrate that approximately 45% to 50% of the United States population fails to meet the Estimated Average Requirement (EAR) for magnesium from total intake (food and supplements), and an even higher percentage fails to meet it from diet alone. For example, NHANES 2003–2006 showed 45% below the EAR, NHANES 2007–2010 showed 46% below the EAR, and analysis across 2003–2018 showed that only about 52% of men and 48.5% of young adults met the EAR.

1:31:26Rhonda Patricksupportedmoderate

Taking NSAIDs like ibuprofen around exercise blunts muscular training adaptations by inhibiting prostaglandins and inflammatory responses.

"it's been shown if you take NSAIDs, right, so these non-steroidal anti-inflammatory drugs, something like ibuprofen around exercise, it can blunt the adaptations because it's basically lowering inflammation and prostaglandins and things that are important to cause exercise adaptations." (said at 1:31:26)

Randomized controlled trials and physiological reviews confirm that regular or high-dose NSAID consumption (such as ibuprofen at 1,200 mg/day) can attenuate muscle hypertrophy and strength adaptations to resistance training in young, healthy adults. Mechanistically, NSAIDs inhibit cyclooxygenase (COX) enzymes, which reduces prostaglandin synthesis and transient inflammatory signaling necessary for optimal muscle protein turnover and satellite cell proliferation. However, this blunting effect is most pronounced with chronic high doses in young individuals; in older adults with elevated baseline chronic inflammation, NSAIDs may not exhibit this blunting effect.

1:32:00Rhonda Patricksupportedlow

Individuals taking TNF-alpha inhibitor drugs have approximately a 50% lower risk of developing Alzheimer's disease.

"Those individuals taking TNF-alpha inhibitors have like a 50% less likelihood of getting Alzheimer's disease than people—" (said at 1:32:00)

Multiple large observational and claims database studies have reported that patients with inflammatory conditions (such as rheumatoid arthritis or psoriasis) who are treated with TNF-alpha inhibitors have an approximately 40% to 70% lower risk (commonly cited as ~50%) of developing Alzheimer's disease compared to unexposed patients. However, the evidence is observational (retrospective cohort and nested case-control designs), which limits causal certainty.

1:06:59Rhonda Patricksupportedhigh

Reverse osmosis water filtration removes essential minerals and trace elements such as phosphorus, manganese, and iodine from drinking water.

"and then the last thing I want to mention, Steven, because you do have a reverse osmosis water filter, is that it does filter out a lot of small particles, including essential, you know, trace elements and some essential like minerals and stuff. So, you want to make sure that you are taking a multivitamin mineral supplement. And you can also get what's called little essential element drops that have things like phosphorus, manganese, iodine, some of these things that are being filtered out of your water" (said at 1:06:59)

Reverse osmosis (RO) membrane filtration non-selectively removes dissolved ions, minerals, and trace elements (typically by 90–99%) from drinking water along with contaminants. Water quality analyses consistently demonstrate that RO filtration significantly depletes minerals and trace elements (such as phosphorus, calcium, magnesium, and other dissolved ions) from tap water compared to unfiltered water or simpler filtration methods.

1:12:02Rhonda Patricksupportedhigh

Melanin acts as a natural sunscreen, requiring individuals with darker skin pigmentation to spend significantly more time in the sun to synthesize vitamin D.

"well, you go outside, but you have darker skin, so melanin is a natural sunscreen, and so people with more melanin have to spend a lot more time in the sun, and so that is something to consider as well." (said at 1:12:02)

Melanin acts as a natural photoprotective filter that absorbs ultraviolet B (UVB) radiation, competing with 7-dehydrocholesterol in the skin. Consequently, individuals with darker skin pigmentation (higher melanin content) require significantly longer sun exposure compared to individuals with lighter skin to synthesize equivalent amounts of vitamin D.

1:17:00Rhonda Patricksupportedhigh

Magnesium acts as an essential cofactor for over 300 different enzymatic reactions in the human body and is required for DNA repair.

"Magnesium is running—it's important for 300 different enzymes in your body. It's important to repair damage to your DNA that's being done all the time." (said at 1:17:00)

The speaker's statement accurately reflects established biochemical and physiological knowledge. Magnesium serves as an essential cofactor for over 300 distinct enzymatic systems in the human body (including those involved in ATP utilization, energy metabolism, and protein synthesis) and is an essential cofactor for the enzymatic machinery of major DNA repair pathways (including nucleotide excision repair, base excision repair, and mismatch repair).

1:14:56Rhonda Patricksupportedhigh

Curcumin supplementation significantly lowers circulating levels of the inflammatory cytokine TNF-alpha.

"Curcumin hasn't been shown to do that, but it has been shown to lower something called TNF-alpha. And that is a major inflammatory cytokine that is really, really powerfully accelerating aging." (said at 1:14:56)

Multiple comprehensive systematic reviews, meta-analyses, and umbrella reviews of randomized controlled trials (RCTs) demonstrate that curcumin supplementation significantly reduces circulating levels of tumor necrosis factor-alpha (TNF-α), a key pro-inflammatory cytokine. For instance, a 2023 meta-analysis of 66 RCTs found a significant reduction in TNF-α (WMD = -3.48 pg/ml), and umbrella meta-analyses pooling extensive randomized clinical trial data confirm consistent, statistically significant reductions in TNF-α alongside other inflammatory markers.

1:32:49Rhonda Patricksupportedmoderate

Curcumin lowers circulating TNF-alpha levels by almost 5 picograms per milliliter.

"curcumin is one of the most—it is the most naturally occurring dietary compound that I've seen data showing that it lowers TNF-alpha. I haven't seen anything else that's naturally occurring that does it. This does it. It lowers it by quite a bit, by almost 5 picograms per milliliter." (said at 1:32:49)

The speaker's specific claim that curcumin lowers circulating TNF-alpha by 'almost 5 picograms per milliliter' is directly supported by a 2016 meta-analysis of randomized controlled trials by Sahebkar et al. (PMID 27025786), which reported a weighted mean difference (WMD) of -4.69 pg/mL (95% CI: -7.10 to -2.28, p < 0.001). Subsequent larger meta-analyses continue to confirm that curcumin significantly reduces TNF-alpha levels, though with somewhat smaller pooled effect sizes (e.g., -1.61 pg/mL in a 2021 meta-analysis and -2.72 pg/mL in an umbrella review).

1:33:51Rhonda Patricksupportedhigh

Urolithin A is produced by gut bacteria from ellagitannins found in foods such as pomegranates.

"The other supplement that I really want to talk about is urolithin A. And as I mentioned, this is a compound that's usually generated in the gut by the bacteria in your gut. It's something that we can get from our diet. So if we eat things like pomegranate, pomegranate has a type of polyphenol in it called ellagitannins." (said at 1:33:51)

Extensive human and biochemical research demonstrates that urolithin A is a microbial metabolite produced by gut bacteria from dietary ellagitannins and ellagic acid, polyphenols abundant in foods such as pomegranates, berries, and walnuts. Clinical trials show that dietary intake of pomegranate juice leads to urolithin A production in individuals with a competent gut microbiome composition.

1:34:10Rhonda Patricksupportedmoderate

Approximately 50% of the human population lacks the gut bacteria required to synthesize urolithin A from diet.

"However, 50% of the population doesn't have the right bacteria to make it. So you're kind of like a coin toss if you eat pomegranate: am I going to be the person that can make urolithin A or am I not, right?" (said at 1:34:10)

The speaker's statement that approximately 50% of people lack the gut bacterial profile required to convert dietary precursors (such as ellagitannins from pomegranates) into urolithin A is consistent with human clinical evidence. In clinical trials evaluating urolithin conversion after pomegranate intake, only about 40% of participants demonstrated significant production of urolithin A, which correlated with distinct gut microbiota composition and diversity (PMID: 34117375). Across various cohort studies, human populations fall into different urolithin metabotypes, with substantial proportions unable to produce urolithin A efficiently or at all (PMID: 24976365).

1:35:10Rhonda Patricksupportedmoderate

Fasting activates cellular autophagy and mitophagy.

"Fasting activates autophagy. Fasting activates mitophagy, which is specifically just clearing out damaged mitochondria or pieces of damaged mitochondria." (said at 1:35:10)

Nutrient deprivation and fasting trigger energy-sensing pathways (such as AMPK activation and mTOR inhibition) that stimulate macroautophagy and selective mitochondrial autophagy (mitophagy), the cellular quality-control process responsible for the degradation and clearance of dysfunctional or damaged mitochondria. This fundamental biological mechanism is well-documented in preclinical models and synthesized across extensive review literature.

1:36:10Rhonda Patricksupportedmoderate

Human muscle biopsy studies confirm that oral urolithin A activates mitophagy.

"For one, urolithin A and mitophagy was shown to be activated in humans taking it. So they took muscle biopsies and found that, in fact, mitophagy was activated." (said at 1:36:10)

Randomized clinical trials administering oral urolithin A to human participants with skeletal muscle biopsies have demonstrated that urolithin A upregulates mitochondrial gene expression and increases the levels of proteins linked to mitophagy and mitochondrial metabolism in human skeletal muscle tissue.

1:36:23Rhonda Patricksupportedmoderate

1,000 mg per day of urolithin A in older adults increases CD8-positive T cells and natural killer cells while reducing markers of cellular senescence.

"So older adults were given 1,000 milligrams a day, and as we age, our immune system ages, our T cells aren't fighting off pathogens as well, and it increased the number of a very specific type of immune cell that decreases with age called CD8-positive T cells. Those were increased... And then it also increased a kind of immune cell that's able to kill cancer cells and also kill viruses and pathogens; it's called natural killer cells. So those cells increased as well with the urolithin A, and it also decreased markers of senescence." (said at 1:36:23)

A double-blind, randomized, placebo-controlled clinical trial evaluated 1,000 mg/day of oral urolithin A (UA) for 4 weeks in 50 healthy adults (NCT05735886; published in Nature Aging). The trial found that UA supplementation significantly expanded naive-like, less terminally exhausted CD8+ T cells, increased peripheral CD56dimCD16bright natural killer (NK) cells, augmented CD8+ mitochondrial biogenesis and fatty acid oxidation capacity, and modulated pathways linked to senescence and inflammaging.

  • supports: Effect of the mitophagy inducer urolithin A on age-related immune decline: a randomized, p… (Nature aging 2025) · cited 32x in the literature
    "In this randomized, double-blind, placebo-controlled trial, 50 healthy middle-aged adults received oral UA (1,000 mg day -1 ) or placebo for 4 weeks; time points of analysis were baseline and day 28... UA expanded peripheral naive-like, less terminally exhausted CD8 + cells (treatment difference 0.50 percentage points; 95% CI = 0.16 to 0.83; P = 0.0437)... Analysis revealed augmented mitochondrial biogenesis in CD8 + cells, increased peripheral CD56 dim CD16 bright NK cells, and nonclassical CD14 lo CD16 hi monocytes in UA-treated participants" (abstract, results)
    pubmedfull study (doi)
1:39:00Rhonda Patricksupportedhigh

Glutamine is metabolized into glutamate for cellular energy and into alpha-ketoglutarate, which serves as an energy substrate for gut cells.

"Two, it can form something called glutamate, which is used by your cells for energy—mitochondria love it—or it can be converted into that neurotransmitter that we were talking about, right? Glutamate... The other thing it's good for is the gut. And that is because glutamine can be converted into something called alpha-ketoglutarate, which is an important energy compound that the gut uses." (said at 1:39:00)

The speaker's statement accurately describes established human metabolic pathways. Glutamine is converted to glutamate via glutaminase (glutamate can function as an excitatory neurotransmitter and metabolic substrate), and glutamate is subsequently transaminated or dehydrogenated into alpha-ketoglutarate, an essential citric acid cycle intermediate that serves as a primary oxidative fuel substrate for intestinal enterocytes.

1:42:20Rhonda Patricksupportedhigh

1,3-butanediol is metabolized in the liver to form beta-hydroxybutyrate.

"Ketone-IQ has got the precursor for the ketone. It's got 1,3-butanediol that in your liver gets converted into beta-hydroxybutyrate." (said at 1:42:20)

1,3-butanediol (1,3-BD) is an established ketogenic precursor that undergoes hepatic metabolism into beta-hydroxybutyrate (BHB). Pharmacokinetic and biochemical studies in both human and animal liver fractions and in vivo models confirm that the liver is the primary site of conversion of (R)-1,3-butanediol to (R)-beta-hydroxybutyrate.

1:45:24Rhonda Patricksupportedhigh

Exogenous ketones transiently shut down endogenous lipolysis for up to three hours.

"For people that are fasting and they're wanting to burn fat, consider that if you take exogenous ketones, you stop you stop burning your own fat because your body thinks it's now got all it's got the ketones there... And so, it does shut down what's called lipolysis, which is basically breaking down fat... it's only going to last as long as the beta-hydroxybutyrate lasts in your in your blood system. So, you know, maybe three hours max." (said at 1:45:24)

The speaker claimed that taking exogenous ketones transiently shuts down endogenous lipolysis (burning your own fat) for the duration that beta-hydroxybutyrate (BHB) remains elevated (around a few hours). This is supported by human clinical trials and mechanistic physiological studies demonstrating that exogenous BHB acts directly via the HCAR2 (GPR109A) receptor on adipocytes and/or negative feedback loops to profoundly suppress lipolysis and reduce circulating free fatty acids (FFAs) acutely for the duration of elevated plasma ketone levels.

1:51:45Rhonda Patricksupportedmoderate

Fluid cognitive function peaks around age 25, whereas crystallized intelligence peaks in midlife around age 40 to 45.

"We have fluid cognitive function like processing speed. That is the kind of I would say cognitive function where you can answer a question without any prior knowledge... So that peaks around 25... And then we have the crystallized cognitive function. Crystallized cognitive function is interesting because it peaks around midlife. And the reason it peaks around 40, 45 is because it's the kind of intelligence that it's like the library where you have all these facts that you've accumulated over the years" (said at 1:51:45)

The speaker accurately describes the classical distinction and life-span trajectories of fluid versus crystallized intelligence. Standardized normative intelligence testing and large-scale lifespan cognitive assessments show that fluid cognitive measures (e.g., perceptual reasoning, processing speed, matrix reasoning) generally peak in early adulthood (around ages 20–29 / ~25 years) and decline thereafter, whereas crystallized cognitive measures reflecting accumulated knowledge and vocabulary peak substantially later in midlife (between ages 30–50+).

1:55:40Rhonda Patricksupportedmoderate

Aerobic exercise stimulates the production of brain-derived neurotrophic factor (BDNF), promotes neurogenesis, and increases brain plasticity.

"Aerobic exercise is increasing brain-derived neurotrophic factor. Very important for both these aspects. It's also, you know, growing new neurons, making connections between the neurons, making your brain more plastic and adaptable so it adapts to the changing environment." (said at 1:55:40)

A substantial body of evidence, including systematic reviews and meta-analyses in humans and experimental models, confirms that aerobic exercise increases circulating and central levels of brain-derived neurotrophic factor (BDNF), enhances neuroplasticity and synaptogenesis, and promotes adult hippocampal neurogenesis.

1:59:27Rhonda Patricksupportedmoderate

Exercising 5 hours per week including high-intensity interval training can reverse cardiac aging by 20 years.

"I mean we talked last time I was here we talked about that study: you exercise 5 hours a week, do some high-intensity interval training in there, and you can reverse heart aging by 20 years." (said at 1:59:27)

The statement accurately reflects the findings of a 2-year prospective randomized controlled trial led by Dr. Benjamin Levine and colleagues (Howden et al., 2018, Circulation). In the trial, sedentary middle-aged adults (mean age 53 years) were assigned to 2 years of structured exercise training (4–5 sessions per week, progressing to ~5 hours per week including 4x4 high-intensity interval training) or control. The exercise intervention significantly reversed sedentary age-related left ventricular stiffness and improved cardiorespiratory fitness (VO2 max increased by 18%), restoring myocardial compliance and distensibility toward levels typically seen in younger individuals (~20 years younger).

1:51:26Rhonda Patricksupportedmoderate

Peak muscle mass and peak bone density generally occur around 25 years of age before beginning to decline.

"Musculoskeletal, right? So this is our peak strength, peak muscle mass, peak bone density. Those also peak around 25 and then they kind of steadily start to decline." (said at 1:51:26)

The speaker's statement that peak musculoskeletal parameters (peak bone density, peak muscle mass, and peak strength) generally peak around age 25 before beginning an age-related decline is well supported by physiological and longitudinal cohort studies. Peak bone mineral density (BMD) and bone mineral content across major skeletal sites (femoral neck, spine, total body) are typically attained between the early twenties and early thirties (averaging around 24 to 26 years of age), after which bone and muscle mass plateau and gradually begin their age-related decline.

1:57:11Rhonda Patricksupportedvery low

Novel cognitive experiences and learning new things stimulate the production of brain-derived neurotrophic factor (BDNF) in the brain.

"there's neurochemical things that are changing when you're learning new experiences. For one, you are increasing brain-derived neurotrophic factor and stuff as well, because novelty does that." (said at 1:57:11)

The speaker's statement that novel experiences and learning increase brain-derived neurotrophic factor (BDNF) is supported by neurobiological literature, particularly in animal models of novelty exploration, behavioral tagging, and environmental enrichment. Studies demonstrate that exposure to novel environments and learning paradigms triggers the synthesis and upregulation of plasticity-related proteins, including BDNF, in brain regions such as the hippocampus, striatum, and prefrontal cortex. Because direct measurement of brain BDNF expression during novelty exposure relies primarily on animal models, certainty is graded as very low.

2:04:41Steven Bartlett (host)supportedmoderate

London taxi drivers have physically larger hippocampus regions due to spatial learning required for 'The Knowledge'.

"They have to learn 25,000 streets and it's called The Knowledge, and they have physically larger hippocampus centers in their brain, which is the memory center." (said at 2:04:41)

Published neuroimaging studies by Eleanor Maguire and colleagues demonstrate that London taxi drivers acquire structural brain changes during their training for 'The Knowledge' (which requires memorizing approximately 25,000 streets and thousands of landmarks). Specifically, structural MRI analyses demonstrate a selective increase in gray matter volume in the posterior hippocampus. A landmark longitudinal study (Woollett & Maguire, 2011) tracked trainees over several years and showed that those who successfully qualified developed significant posterior hippocampal enlargement compared to those who failed or controls, demonstrating that spatial learning drives this regional structural change.

2:11:27Rhonda Patricksupportedhigh

Standard public health exercise guidelines recommend 150 to 300 minutes per week of moderate-intensity exercise or 75 to 150 minutes per week of vigorous-intensity exercise.

"typically you'll hear exercise guidelines: 150 to 300 minutes a week of moderate-intensity exercise is good for optimal health, or 75 minutes to 150 minutes a week of vigorous-intensity exercise." (said at 2:11:27)

Standard public health exercise guidelines, such as the World Health Organization (WHO) 2020 Guidelines on Physical Activity and Sedentary Behaviour and the US Physical Activity Guidelines for Americans, recommend that adults engage in 150 to 300 minutes of moderate-intensity aerobic physical activity per week, 75 to 150 minutes of vigorous-intensity aerobic physical activity per week, or an equivalent combination of both.

2:12:04Rhonda Patricksupportedmoderate

To achieve the same reduction in cardiovascular disease mortality as 1 minute of vigorous exercise, an individual must perform 8 minutes of moderate-intensity or 200 minutes of light exercise.

"For every one minute of vigorous-intensity exercise to reduce your death from cardiovascular disease, you had to do eight minutes of moderate intensity and 200 minutes of light exercise." (said at 2:12:04)

A prospective cohort study of 73,485 UK Biobank participants wearing accelerometers (PMID 41057301) analyzed the health equivalence of different physical activity intensities. For a standardized 5% to 35% risk reduction in cardiovascular disease (CVD) mortality, 1 minute of vigorous physical activity (VPA) was equivalent to a median of 7.8 minutes (95% CI: 7.7–8.0) of moderate physical activity (MPA), closely matching the speaker's figure of 8 minutes. Light physical activity (LPA) required substantially higher volumes (tens to hundreds of minutes depending on the outcome and curve interval) to achieve equivalent risk reductions.

2:12:24Rhonda Patricksupportedmoderate

To achieve the same reduction in type 2 diabetes risk as 1 minute of vigorous-intensity exercise, an individual must perform 10 minutes of moderate-intensity exercise or 100 to 200 minutes of light physical activity.

"to reduce your type 2 diabetes risks. For every one minute of vigorous, you had to do 10 minutes of moderate intensity or you had to do, again, you're in the 100, 150 minutes to 200 minutes of light exercise." (said at 2:12:24)

A prospective cohort study of 73,485 UK Biobank participants using wrist accelerometers evaluated the health equivalence of physical activity intensities. For type 2 diabetes risk reduction (standardized 5% to 35% risk reduction), 1 minute of vigorous physical activity (VPA) was equivalent to a median of 9.4 minutes (95% CI: 9.3-9.6) of moderate physical activity (MPA) and 94 minutes of light physical activity (LPA), closely matching the speaker's stated ratios of ~10 minutes of moderate activity or ~100 to 150+ minutes of light activity.

2:12:35Rhonda Patricksupportedmoderate

To achieve the same reduction in cancer mortality as 1 minute of vigorous exercise, an individual must perform about 4 minutes of moderate-intensity exercise or 250 to 300 minutes of light activity.

"To reduce your risk of dying from cancer, for every one minute of vigorous-intensity exercise, you had to do four minutes about four minutes of moderate intensity. And for light, it was like I it was almost not not even happening. I mean, it was like 250, 300." (said at 2:12:35)

The claim accurately describes findings from a prospective cohort study of 73,485 UK Biobank participants using wearable accelerometers (PMID 41057301). The study determined that for cancer mortality risk reduction, 1 minute of vigorous physical activity (VPA) is equivalent to approximately 3.5 to 4 minutes of moderate physical activity (MPA). Light physical activity (LPA) showed very weak associations with cancer mortality, requiring disproportionately large amounts (or failing to achieve equivalent risk reductions) compared to VPA.

2:14:15Rhonda Patricksupportedmoderate

Accumulating 9 minutes per day of short vigorous exercise is associated with 40% lower cancer-related mortality and 50% lower cardiovascular-related mortality in men and women.

"Now there's bigger studies showing men and women that exercise 9 minutes a day, the short vigorous types of exercise adding up, not 9 minutes altogether, but like a minute here, a minute there, a minute here, right? It adds up: 40% lower cancer-related mortality, 50% lower cardiovascular-related mortality." (said at 2:14:15)

The claim accurately reflects findings from a large prospective cohort study in the UK Biobank (Stamatakis et al., Nature Medicine 2022). In 25,241 non-exercisers (mean age 61.8 years, followed for an average of 6.9 years), accumulating brief 1- to 2-minute bursts of vigorous intermittent lifestyle physical activity (VILPA) throughout the day was associated with a 38-40% reduction in cancer mortality risk and a 48-49% reduction in cardiovascular disease (CVD) mortality risk compared to no VILPA. Because this is based on observational cohort data, residual confounding cannot be entirely ruled out, corresponding to moderate GRADE certainty.

2:19:04Rhonda Patricksupportedhigh

GLP-1 receptor agonist medications increase the risk of gallstones.

"The other thing is gallstones. Um you're getting the increased risk of gallstones, right? Some people's gallbladder has to be removed." (said at 2:19:04)

A comprehensive systematic review and meta-analysis of 76 randomized clinical trials involving 103,371 patients published in JAMA Internal Medicine confirmed that GLP-1 receptor agonist use is associated with a significantly increased risk of gallbladder and biliary diseases (RR 1.37, 95% CI 1.23–1.52), specifically cholelithiasis (gallstones; RR 1.27, 95% CI 1.10–1.47) and cholecystitis (RR 1.36, 95% CI 1.14–1.62). The risk is particularly pronounced when these medications are prescribed at higher doses, for longer durations, or specifically for weight loss (RR 2.29, 95% CI 1.64–3.18).

2:21:03Rhonda Patricksupportedhigh

GLP-1 receptor agonist medications carry an FDA black box warning for thyroid cancer based on animal studies.

"There's a black box warning on them for thyroid cancer increase. That's never really been shown in human studies. It all comes from animal data, but it's there nonetheless." (said at 2:21:03)

GLP-1 receptor agonists carry an FDA boxed warning regarding the risk of thyroid C-cell tumors and medullary thyroid carcinoma (MTC). This regulatory warning is directly based on preclinical rodent carcinogenicity studies showing that sustained GLP-1 receptor activation induces C-cell hyperplasia and adenomas/carcinomas in rats and mice. In contrast, primate and human C-cells express vastly lower levels of GLP-1 receptors, and human clinical trials and primate models have not demonstrated corresponding C-cell proliferation or calcitonin increases.

2:19:50Rhonda Patricksupportedhigh

During weight loss diets without resistance training and adequate protein, up to 40% of the total weight lost can come from lean mass.

"there's weight loss studies showing that in any weight loss diet, you know, if you're not eating enough protein and you're not resistance training, up to 40% of your weight can come from muscle weight loss that you're losing. I should say lean mass, including muscle." (said at 2:19:50)

During caloric restriction and weight loss without interventions such as adequate dietary protein and resistance training, lean body mass (fat-free mass, including skeletal muscle) typically accounts for approximately 20% to 30%, and can reach up to 40% to 50%, of total weight lost.

2:35:55Rhonda Patricksupportedmoderate

Omega-3 was the only supplement shown to slow aging in a study of healthy, physically active Swiss participants.

"That's been shown with omega-3. It's absolutely slowing aging. I told you omega-3 was the only supplement that was able to do that. Um, even in the context of people that were healthy and physically active. I mean, this the Swiss these Swiss people are healthy." (said at 2:35:55)

The statement accurately reflects a 2025 post hoc analysis of the DO-HEALTH randomized controlled trial (conducted across European centers including Switzerland in relatively healthy, active older adults). The study evaluated vitamin D3, omega-3, and exercise on four next-generation DNA methylation clocks of biological aging over 3 years. Omega-3 was the only individual supplement tested that demonstrated a statistically significant slowing of biological aging across multiple clocks (PhenoAge, GrimAge2, and DunedinPACE), with an effect size of 2.9 to 3.8 months over 3 years, although all three interventions combined showed additive benefits on PhenoAge. Epigenetic clocks serve as validated surrogate measures of biological aging.

2:36:23Rhonda Patricksupportedhigh

Sleep deprivation negatively affects blood glucose levels.

"I realized how important sleep was for my metabolic health. I thought I was doing everything right for metabolic health and and it was it was knowing how not getting enough sleep was affecting my glucose." (said at 2:36:23)

A 2022 systematic review and meta-analysis of randomized controlled trials (PMID: 35189549) examining sleep manipulation found that experimental sleep restriction significantly reduces whole-body insulin sensitivity and impairs glucose regulation as measured by oral or intravenous glucose tolerance tests and HOMA-IR. Extensive experimental literature consistently confirms that acute and chronic sleep restriction impairs glucose tolerance and metabolic control.

10 No source found (not proven false)
0:05:11Rhonda Patrickunverifiedlow

70% of women and 50% of men over the age of 50 have a high amount of visceral fat.

"70% of women over the age of 50 have a high amount of visceral fat. 50% of men over the age of 50 have a high amount of visceral fat." (said at 0:05:11)

No published epidemiological study or meta-analysis was identified supporting the specific claim that exactly 70% of women and 50% of men over the age of 50 have a 'high amount of visceral fat'. While visceral adipose tissue increases with age (particularly post-menopause in women), large population cohorts (such as the German National Cohort) show that men generally accumulate more visceral adipose tissue than women across age groups.

0:05:45Rhonda Patrickunverifiedvery low

People with a high amount of visceral fat are 44% more likely to develop metastatic cancer.

"And for this reason, people with a high amount of visceral fat are 44% more likely to get metastatic cancer." (said at 0:05:45)

A systematic search across PubMed and Europe PMC did not identify any published epidemiological study or meta-analysis showing that individuals with high visceral fat are 44% more likely to develop metastatic cancer. While visceral adiposity is widely studied as a metabolic risk factor associated with the incidence and prognosis of several specific malignancies (such as colorectal or renal cell carcinomas), no study establishing this generalized 44% statistic across metastatic cancers was found.

0:11:30Rhonda Patrickunverifiedlow

A waist circumference of 35 inches or greater for women and 40 inches or greater for men serves as a clinical sign of excessive visceral fat.

"So, like if women have a waist circumference of 35 inches or greater, that is a sign of too much visceral fat. If men have a waist circumference of 40 inches or more, that is a sign of too much visceral fat." (said at 0:11:30)

Within the search query budget, full abstract records containing specific statistical validation data could not be fetched to provide verbatim citations. In major clinical guidelines (such as the NIH/NHLBI and NCEP ATP III guidelines for metabolic syndrome and abdominal obesity), cutoffs of 35 inches (88 cm) for women and 40 inches (102 cm) for men are standard clinical thresholds used as proxies for central/visceral adiposity and elevated cardiometabolic risk in North American populations, though specific cutoffs vary by ethnicity.

0:16:10Rhonda Patrickunverifiedvery low

Healthy young men given a 1,200 to 1,500 calorie daily excess from ultra-processed foods for 5 days gained visceral fat, showed signs of fatty liver, and developed brain insulin resistance.

"So, there was a recent study that, again, was in healthy young men given about 1,200 extra calories a day, and it was mostly from ultra-processed foods, right? ... For 5 days, they were given this extra caloric intake. After that five days, they started to gain visceral fat. They started to have signs of fatty liver after five days, and their brains became insulin resistant." (said at 0:16:10)

No published study matching the specific protocol and findings described by the speaker was identified. While several human overfeeding trials have examined the metabolic consequences of short-term (e.g., 5-day) hypercaloric or high-fat diets in healthy young men—often observing rapid alterations in whole-body/skeletal muscle insulin signaling or hepatic lipid accumulation—no published trial was located demonstrating that 5 days of a 1,200–1,500 kcal/day ultra-processed overfeeding diet simultaneously induced visceral fat accumulation, signs of fatty liver, and central (brain) insulin resistance in healthy young men.

0:38:58Steven Bartlett (host)unverifiedvery low

In men, testosterone and growth hormone levels typically peak in their late 20s.

"And for men, I was reading that testosterone and growth hormone typically peak in their late 20s." (said at 0:38:58)

No published records matching the claim were retrieved and fetched within the search parameters. In endocrine physiology, growth hormone secretion generally peaks during the pubertal growth spurt in adolescence before declining progressively with age (somatopause), and testosterone typically reaches peak levels in late adolescence to early adulthood (around late teens to early 20s) rather than peaking specifically in the late 20s. However, because no specific study evaluating this combined trajectory was fetched in the search, the claim remains unverified under search constraints.

0:39:11Steven Bartlett (host)unverifiedvery low

Between the ages of 25 and 65, men typically experience a 200% increase in visceral fat even if their body weight remains unchanged.

"So between the age of 25 and 65, men typically see a 200% increase in their visceral fat even if their total weight stays the same." (said at 0:39:11)

A systematic search of PubMed and Europe PMC did not identify published studies or epidemiological datasets demonstrating a typical 200% (threefold) increase in visceral adipose tissue specifically between ages 25 and 65 in men whose total body weight remains unchanged. While it is well-established that aging is associated with redistribution of fat and a progressive increase in visceral adiposity independent of total body weight, the precise quantitative figure of a 200% increase across this specific age bracket could not be verified in the peer-reviewed literature. This lack of specific published records does not prove the claim false.

1:05:18Rhonda Patrickunverifiedvery low

Nitrile gloves protect against dermal absorption of BPA from receipts, whereas latex gloves do not.

"nitrile gloves will protect you from from the BPA getting across your your dermal barrier and getting to your bloodstream. Latex gloves do not. So, make sure they're nitrile gloves." (said at 1:05:18)

Studies demonstrate that wearing protective gloves during receipt handling prevents spikes in urinary BPA concentrations among cashiers (e.g., PMID 29778011). However, the specific claim that nitrile gloves protect against dermal absorption of BPA while latex gloves do not is unverified in published biomedical literature. Comparative permeation studies distinguishing latex from nitrile specifically for dry or solvent-facilitated transfer of bisphenols from thermal paper were not found.

1:24:52Rhonda Patrickunverifiedvery low

A consumer testing study found that nearly all commercial creatine gummies tested contained virtually no creatine.

"there was a study that was published not long ago. It was a consumer study that was done where people went and got a lot of different creatine gummies off the shelf and then measured how much creatine was in them. And essentially almost all of them had none." (said at 1:24:52)

No peer-reviewed scientific publication matching this consumer testing study on commercial creatine gummies was identified in PubMed or Europe PMC. This does not prove that no such industry report or third-party consumer analysis (such as testing by independent consumer testing organizations or supplement manufacturers) exists, but there is no published academic record verifying the specific claim.

2:06:58Steven Bartlett (host)unverifiedvery low

A study found that 83% of generative AI users were unable to remember details of text written with AI assistance, and EEG scans showed brain connectivity was nearly halved compared to writing manually.

"83% of AI users were unable to remember the details of a passage of text that they had written with AI's assistance. EEG scans showed that brain connectivity was almost halved when individuals outsourced their thinking to AI compared to writing manually" (said at 2:06:58)

No published study matching the specific statistics (83% of generative AI users unable to remember passage details and EEG functional connectivity being 'almost halved' when using AI versus writing manually) was located in the scientific literature. Existing neuroimaging literature on writing (such as Van der Meer & Van der Weel, 2024) has compared handwriting with digital typewriting rather than generative AI outsourcing, and did not report these figures. This verdict reflects the absence of a published peer-reviewed record matching the claim, which does not definitively prove no such private report or preprint exists.

2:08:17Steven Bartlett (host)unverifiedvery low

In a New York Times profile, Stacy Canterbury lost 50 pounds on a GLP-1 medication and regained 20 pounds within one month after discontinuing it.

"There was a a New York Times piece where they looked at a lady called Stacy Canterbury. She had lost 50 pounds on one of the GLP-1s that you mentioned, reaching her peak goal weight. And after stopping the drug due to insurance issues, she regained 20 pounds back straight away in a month." (said at 2:08:17)

No published peer-reviewed medical study, case report, or clinical record regarding 'Stacy Canterbury' was located in PubMed or Europe PMC. The claim describes an anecdotal patient profile published in popular media (The New York Times) rather than a verified case report in the scientific literature.

Unverified means no publication matching the claim was located; it does not prove the claim false. Spotted an error? See the corrections policy - disputes from the people quoted are prioritized.